US20090069797A1 - Bipolar devices for modification of airways by transfer of energy - Google Patents
Bipolar devices for modification of airways by transfer of energy Download PDFInfo
- Publication number
- US20090069797A1 US20090069797A1 US12/206,591 US20659108A US2009069797A1 US 20090069797 A1 US20090069797 A1 US 20090069797A1 US 20659108 A US20659108 A US 20659108A US 2009069797 A1 US2009069797 A1 US 2009069797A1
- Authority
- US
- United States
- Prior art keywords
- airway
- electrodes
- energy
- active regions
- basket
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/06—Electrodes for high-frequency therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
- A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/08—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by means of electrically-heated probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00115—Electrical control of surgical instruments with audible or visual output
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22062—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation to be filled with liquid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00541—Lung or bronchi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B2018/044—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B2018/044—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid
- A61B2018/046—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid in liquid form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1407—Loop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B2018/1807—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using light other than laser radiation
Definitions
- the invention relates to a device for treating lung disease, and more particularly, the invention relates to a device for transferring energy into airway tissue such as that found in the airways of human lungs. This includes heating and applying RF energy to the airway. In the airways of the lung, the transfer of energy into the airway tissue stiffens that tissue or reduces the ability of the airways to constrict. In general the treatment reduces the resistance to the flow of air through the airway.
- Asthma is a disease in which (i) bronchoconstriction, (ii) excessive mucus production, and (iii) inflammation and swelling of airways occur, causing widespread but variable airflow obstruction thereby making it difficult for the asthma sufferer to breathe.
- Asthma is a chronic disorder, primarily characterized by persistent airway inflammation.
- asthma is further characterized by acute episodes of additional airway narrowing via contraction of hyper-responsive airway smooth muscle.
- Asthma stimuli may be allergenic or non-allergenic.
- allergenic stimuli include pollen, pet dander, dust mites, bacterial or viral infection, mold, dust, or airborne pollutants; non-allergenic stimuli include exercise or exposure to cold, dry air.
- asthma can also lead to remodeling of the airway wall (i.e., structural changes such as thickening or edema) which can further affect the function of the airway wall and influence airway hyperresponsiveness.
- Other physiologic changes associated with asthma include excess mucus production, and if the asthma is severe, mucus plugging, as well as ongoing epithelial denudation and repair.
- Epithelial denudation exposes the underlying tissue to substances that would not normally come in contact with them, further reinforcing the cycle of cellular damage and inflammatory response.
- asthma symptoms include recurrent episodes of shortness of breath (dyspnea), wheezing, chest tightness, and cough.
- dyspnea shortness of breath
- wheezing wheezing
- chest tightness chest tightness
- cough Currently, asthma is managed by a combination of stimulus avoidance and pharmacology.
- Stimulus avoidance is accomplished via systematic identification and minimization of contact with each type of stimuli. It may, however, be impractical and not always helpful to avoid all potential stimuli.
- Asthma is managed pharmacologically by: (1) long term control through use of anti-inflammatories and long-acting bronchodilators and (2) short term management of acute exacerbations through use of short-acting bronchodilators. Both approaches require repeated and regular use of the prescribed drugs. High doses of corticosteroid anti-inflammatory drugs can have serious side effects that require careful management. In addition, some patients are resistant to steroid treatment. Patient compliance with pharmacologic management and stimulus avoidance is often a barrier to successful asthma management.
- the present invention relates to a device for treating airway tissue within the lungs by transfer of energy into the walls of the airway to reduce plugging of the airway, to prevent the airway from being able to constrict, to increase the inner airway diameter, or to reduce resistance to flow through the airway.
- the invention is particularly directed to the treatment of the airways in the lungs to reduce the effects of asthma and other lung disease.
- One variation of the invention includes the transfer of energy to the airway wall via the application of heat.
- an energy transfer apparatus for treating conditions of the lungs by decreasing airway responsiveness includes transferring energy into an airway wall to alter the airway wall in such a manner that the responsiveness of the airway is reduced.
- the inventive device is an energy transfer apparatus which facilitates energy transfer with a mass of tissue within the airways of a lung.
- the inventive device is sized to enter the bronchus or bronchiole of a human lung to conduct energy transfer with the airway tissue therein.
- the inventive device may also be sized to fit within a bronchoscope.
- the bronchoscope may have a channel with a diameter of preferably 2 mm or less.
- a variation of the inventive device includes a flexible elongated body having a proximal portion and a distal portion with a lumen extending between the proximal and distal portions.
- the flexible elongated body may be of sufficient stiffness to pass through a seal of a working channel of a bronchoscope and allow operation of the device through the working channel seal.
- the device may include an expandable portion that is adjacent to a distal portion of the elongated body.
- the expandable portion has a first state, e.g., a size, and a second state where the second state is radially expanded in size from the elongated body.
- the device may include a temperature detecting element which is placed near to the expandable portion.
- the device also includes at least one energy transfer element at an exterior of the expandable portion, where the energy transfer elements are configured to contact the wall of the bronchus or bronchiole when the expanded portion is in an expanded state.
- the device may also include a deployment member that is configured to move the expandable portion between the first and second radially expanded states.
- the deployment member may extend between the expandable portion and the proximal portion of the elongated body.
- the inventive device may further include a distal tip located at a distal end of the apparatus.
- One variation of the inventive device includes an expandable portion that has a diameter of less than 15 mm when in a second expanded state.
- Another variation of the invention includes an expandable portion which includes pre-shaped tines.
- Such tines are configured to be in a first state within an elongated body and, when advanced out of the elongated body, to expand into a second expanded state.
- the tines may be connected to each other with an expanding element to prevent the tines from entering multiple airways at a bifurcation.
- Another variation of the invention includes an expandable portion comprised of a balloon.
- This variation of the invention may include the use of a fluid which may expand the balloon into the second state.
- Yet another variation of this invention includes the use of a heat generating element in the balloon which conducts heat to the fluid to heat an exterior of the balloon. In this variation, the exterior of the balloon serves as the energy transfer element.
- a further variation of the inventive device includes an expandable portion which comprises a plurality of legs which forms a basket.
- the legs of this variation may extend from a proximal joint that is found at an intersection of a distal portion of the elongated body to a distal joint that is adjacent to a distal tip.
- Each leg may have a center that is substantially parallel to the elongated body so that there is sufficient contact between the airway walls and the parallel portion of the leg.
- the center that is substantially parallel is usually referred to as the active region of the leg.
- the legs of this variation may be spaced around a circumference of the elongated body to form a basket.
- the legs of this variation may have a circular cross section or a rectangular cross section, or other non-axisymmetric cross sections.
- the cross sections may be chosen to allow ready deployment from a first state to a second expanded state, while resisting out-of-plane bending which may distort the spacing of the legs or the contact of electrodes with the airway surface.
- One variation of the invention includes a basket in which the distance between the proximal and distal joint is less than 35 mm when the basket is not expanded.
- Another variation of this invention includes a basket that comprises four or five legs. In this case, the legs may be placed evenly around a circumference of the elongated body.
- the legs may be found at intervals of 90 or 72 degrees.
- Other variations of the invention include devices having less than four legs or more than five legs.
- Another variation of this inventive device includes placing a temperature detecting element on one or on more legs. In this variation, the temperature of one leg may be monitored or the temperature of several legs may be independently monitored to control the energy delivery. In a further variation, multiple temperature sensing elements may be combined with independent control of energy to each leg. Both of these variations may also apply to a variation of the device having pre-shaped tines.
- the legs may be soldered or made to adhere using adhesives to the elongated body at the proximal and distal ends.
- Another variation of the invention includes a multi-lumen elongated body into which a portion of each leg is inserted. It is also contemplated that an elongated member may be reinforced via a reinforcing member. Such a reinforcing member may include a coiled or braided wire, polymeric insert, or any other similar reinforcing member.
- the energy transfer element of the invention may include an element that directly heats tissue by delivering current such as an RF based electrode.
- the RF electrode may be either bipolar or monopolar or a heated element that conductively heats tissue.
- the frequency of the RF may be selected to be in the 400 kHz range or any other standard medical range used in electro-surgical applications.
- the heated element may use AC or DC current to resistively heat the element.
- RF energy may also be used to resistively heat the element.
- An indirect method of heating includes a resistively heated element that conducts heat to the expandable portion or directly to the airway.
- the invention may also include a combination of the types of electrodes mentioned above.
- each of the energy transfer elements may be a RF electrode that is attached to each leg.
- the electrode may be fastened by a heat shrink fastener.
- a temperature detecting element may be placed on the leg and underneath the fastener.
- a resistance heating element may be coiled around a portion of the leg.
- a temperature detecting element may be placed underneath the coil.
- Other examples of the energy transfer element include a polymeric heating element, an electrically conductive paint, or a printed flex circuit which are on a portion of the leg.
- Another variation employs the basket leg itself as either a RF electrode or a heated element. In such cases, the temperature sensing element may be attached directly to a basket leg by soldering, welding, adhesive bonding, or other means.
- Another variation of the invention includes a sheath slidably coupled to and exterior to the expandable portion.
- the expandable portion may be resilient and self-expand into the second state when no longer confined by the sheath. For example, the sheath may be withdrawn in a proximal direction or the expandable portion may be advanced out of the sheath.
- Yet another variation of the invention includes a deployment member comprising a handle adjacent to a proximal end of the elongated body.
- the elongated body may be slidably attached to the handle.
- the deployment member may also comprise a wire that extends from the handle through the lumen of the elongated body and is fixedly attached to the distal tip. This wire may also provide a current to the energy transfer members.
- the elongated body, the wire, and the distal tip may be slidably moveable in a distal and proximal direction.
- This variation of the deployment member may also include a stop configured to prevent distal movement of the wire beyond a deployment point. In this variation, beyond the deployment point, movement of the elongated body against the non-moving distal tip causes the expansion member to expand from a first state into a second expanded state.
- a deployment member comprising a sheath that covers the elongated member and expandable portion and a handle at a proximal end of the sheath.
- the sheath may be slidably attached to the handle while the elongated member is rigidly attached to the handle.
- a wire may extend from said handle to a distal tip through a lumen of the elongated member.
- the variation may include a first control member attached to the sheath and slidably attached to the handle where proximal movement of the first control member causes the sheath to retract on the elongated member and uncover the expandable portion.
- This variation may also include a second control member which is attached to the wire where proximal movement of the second control member causes the distal tip and the expandable portion to retract against the non-moving elongated member and causes the expandable portion to radially expand into a second state.
- Another variation of the invention includes a deployment member having force compensation or deflection limiting stops to prevent over-expansion of the expandable member when deployed within the body.
- a variation of the invention includes placing a sheath exterior to the elongated body and expandable portion such that the expandable portion is placed within the sheath in a first unexpanded state. When the expandable portion is no longer restrained by the sheath, the expandable portion expands into its second state.
- the invention may also include a control member moveably secured to the handle where the member is configured to advance the elongated body and the wire in the distal and proximal directions.
- Another variation of the invention includes a detent means for maintaining the elongated body distally of the deployment point.
- the control member may also be configured to frictionally maintain the elongated body distally of the deployment point. In these cases, the expandable portion will be in the second expanded state.
- Other variations of the inventive device may include use of levers, control wheels, or screw mechanisms in place of a control member.
- Another variation of the inventive device includes a distal tip that may be configured to prevent gouging of the airway tissue.
- the distal tip may have a redundant joint to prevent separation of the tip from the apparatus.
- the distal tip may also be sized to fit within a bronchoscope.
- Another variation of the invention includes a central wire extending from the distal tip to the proximal portion of the device.
- the wire may be configured to provide a current to the energy transfer elements.
- a temperature detecting element may also be attached to the wire.
- the inventive device may also be radiopaque or may have radiopaque elements.
- Another variation of the invention includes providing a steering member in the device to deflect the distal tip of the apparatus in a desired direction.
- the vision system may include a fiber-optic cable or a CCD chip.
- Another variation of the invention includes providing a power supply configured to deliver energy through the energy transfer elements to the airway walls.
- the power supply may be configured to include a high temperature shut off or one which shuts down if a minimum temperature is not detected within a predetermined time or if a minimum temperature slope is not detected during a predetermined time.
- the invention further includes a kit comprising an energy transfer apparatus for facilitating energy transfer into a mass of airway tissue and a generator configured to delivery energy to the energy transfer apparatus.
- the kit may further include a bronchoscope.
- the invention further includes an energy transfer apparatus for facilitating energy transfer into a mass of airway tissue within a lung, the energy transfer apparatus having been rendered sterile for the purposes of prevention of infection of the lung.
- the invention further includes a modified lung configured to have an artificially altered airway within the lung, the airway being artificially altered by transfer of energy to the airway such that the airway has a reduced ability to constrict, an increased airway diameter, a increase in resistance to plugging, and a decrease in resistance to airflow.
- the present invention may be used for a treatment of asthma or other constriction or spasm of a bodily conduit by application of energy.
- the treatment reduces the ability or propensity of the airway to contract, reduces plugging of the airway, increases the inner airway diameter, and/or reduces resistance to flow through the airway.
- FIG. 1 is a cross sectional view of a medium sized bronchus in a healthy patient.
- FIG. 2 is a cross sectional view of a bronchiole in a healthy patient.
- FIG. 3 is a cross sectional view of the bronchus of FIG. 1 showing the remodeling and constriction occurring in an asthma patient.
- FIG. 4 is an illustration of the lungs being treated with a device according to the present invention.
- FIG. 5A is a partial side view of a variation of the inventive device having a plurality of wire shaped electrodes.
- FIG. 5B is a cross sectional side view of another variation of a device having a plurality of wire shaped electrodes with a deployment wire attached to a distal tip of the device.
- FIG. 5C shows a partial view of a variation of an elongated member of inventive device having a plurality of lumens for nesting the legs of the basket.
- FIGS. 5D-5I illustrate a variation of the invention and a deployment member for deploying the device.
- FIGS. 5J-5L illustrate examples of energy transfer elements of the device.
- FIG. 5M shows a partial view of a thermocouple attached to a basket leg.
- FIGS. 6A-6D illustrates distal joints of the invention.
- FIG. 6E illustrates a proximal joint of the invention.
- FIGS. 7A-7D illustrates a series and parallel wiring of legs of the basket.
- FIGS. 8A-8C illustrate examples of variable thicknesses of legs of the basket.
- FIGS. 9A-9D illustrate examples of a basket formed from a single sheet or piece of material.
- FIG. 10 is a side cross sectional view of a variation of the inventive device having a balloon with electrodes positioned exterior to the balloon.
- FIG. 11 is a partial side view of a variation of the inventive device having a balloon with heat generating elements positioned within the balloon for indirect heating of the tissue.
- FIG. 12 is cross sectional view of the inventive device with electrodes and pre-shaped tines as the expandable member.
- FIG. 13 is a cross sectional view of a variation of the inventive device with energy transfer elements positioned on expandable balloons.
- FIG. 14 is an illustration of a variation of the inventive device with electrodes positioned in grooves.
- FIG. 15 is an illustration of a variation of the inventive device with electrodes and a biasing element.
- FIG. 16 is an illustration of another variation of the inventive device having electrodes and a biasing element.
- FIG. 17 is a partial side view of a variation of the inventive device having electrodes exposed by cut away sections of an elongated member.
- FIG. 18 is a partial side view of the inventive device with electrodes positioned on a loop shaped member.
- FIG. 19 is a cross sectional view of a variation of the inventive device having a looped shaped electrode in an unexpanded position.
- FIG. 20 is a cross sectional view of the variation of FIG. 19 with the looped shape electrode in an expanded position.
- the inventive airway energy treatment may be used to reduce the ability of the airways to narrow or to reduce in diameter due to airway smooth muscle contraction.
- This treatment to reduce the ability of the smooth muscle to contract lessens the severity of an asthma attack.
- the reduction in the ability of smooth muscle to contract may be achieved by treating the smooth muscle itself or by treating other tissues which in turn influence smooth muscle contraction or the response of the airway to smooth muscle contraction.
- Treatment may also reduce airway responsiveness or the tendency of the airway to narrow or to constrict in response to a stimulus.
- the amount of smooth muscle surrounding the airway can be reduced by exposing the smooth muscle to energy which either kills the muscle cells or prevents these cells from replicating.
- the reduction in smooth muscle reduces the ability of the smooth muscle to contract and to narrow the airway during a spasm.
- the reduction in smooth muscle and surrounding tissue has the added potential benefit of increasing the caliber or diameter of the airways, reducing the resistance to airflow through the airways.
- the device of the present invention may also be used for eliminating the smooth muscle altogether by thermally damaging or destroying it. The elimination of the smooth muscle prevents the hyper-reactive airways of an asthma patient from contracting or spasming, reducing or eliminating this asthma symptom.
- the ability of the airway to contract can also be altered by treatment of the smooth muscle in particular patterns.
- the smooth muscle is arranged around the airways in a generally helical pattern with pitch angles ranging from about ⁇ 30 to about +30 degrees.
- the treatment of the smooth muscle by energy which is selectively delivered in an appropriate pattern interrupts or cuts through the helical pattern at a proper pitch and prevents the airway from constricting.
- This procedure of patterned application of energy eliminates contraction of the airways without completely eradicating smooth muscle and other airway tissue.
- a pattern for treatment may be chosen from a variety of patterns including longitudinal or axial stripes, circumferential bands, helical stripes, and the like as well as spot patterns having rectangular, elliptical, circular or other shapes.
- the size, number, and spacing of the treatment bands, stripes, or spots are chosen to provide a desired clinical effect of reduced airway responsiveness while limiting insult to the airway to a clinically acceptable level.
- the patterned treatment of the tissues surrounding the airways with energy provides various advantages.
- the careful selection of the portion of the airway to be treated allows desired results to be achieved while reducing the total healing load.
- Patterned treatment can also achieve desired results with decreased morbidity, preservation of epithelium, and preservation of a continuous or near continuous ciliated inner surface of the airway for mucociliary clearance.
- the pattern of treatment may also be chosen to achieve desired results while limiting total treatment area and/or the number of airways treated, thereby improving speed and ease of treatment.
- Application of energy to the tissue surrounding the airways also may be used to cause the DNA of the cells to become cross linked.
- the treated cells with cross linked DNA are incapable of replicating. Accordingly, over time, as the smooth muscle cells die, the total thickness of smooth muscle decreases because of the inability of the cells to replicate.
- the programmed cell death causing a reduction in the volume of tissue is called apoptosis.
- This treatment does not cause an immediate effect but causes shrinking of the smooth muscle and opening of the airway over time and substantially prevents re-growth.
- the application of energy to the walls of the airway may also be used to cause a cross linking of the DNA of the mucus gland cells thereby preventing them from replicating and reducing excess mucus plugging or production over time.
- the ability of the airways to contract may also be reduced by altering mechanical properties of the airway wall, such as by increasing stiffness of the wall or by increasing parenchymal tethering of the airway wall. Both of these methods increase the strength of the airway wall and opposes contraction and narrowing of the airway.
- One way to increase stiffness is to induce fibrosis or wound healing response by causing trauma to the airway wall.
- the trauma can be caused by delivery of therapeutic energy to the tissue in the airway wall or by mechanical insult to the tissue.
- the energy is preferably delivered in such a way that it minimizes or limits the intra-luminal thickening that can occur.
- Another way to increase the effective stiffness of the airway wall is by altering the submucosal folding of the airway upon narrowing.
- the submucosal layer is directly beneath the epithelium and its basement membrane and inside the airway smooth muscle.
- the mucosal folds mechanically interfere with each other, effectively stiffening the airway.
- the number of folds is fewer and the size of the folds is larger, and thus, the airway is free to narrow with less mechanical interference of mucosal folds than in a healthy patient.
- asthmatic patients have a decrease in airway stiffness and the airways have less resistance to narrowing.
- the mucosal folding in asthmatic patients can be improved by treatment of the airway in a manner which encourages folding.
- a treatment will increase the number of folds and/or decrease the size of the folds in the mucosal layer.
- treatment of the airway wall in a pattern such as longitudinal stripes can encourage greater number of smaller mucosal folds and increase airway stiffness.
- the mucosal folding can also be increased by encouraging a greater number of smaller folds by reducing the thickness of the submucosal layer.
- the decreased thickness of the submucosal layer may be achieved by application of energy which either reduces the number of cells in the submucosal layer or which prevents replication of the cells in the submucosal layer.
- a thinner submucosal layer will have an increased tendency to fold and increased mechanical stiffening caused by the folds.
- the parenchyma surrounds airways and includes the alveolus and tissue connected to and surrounding the outer portion of the airway wall.
- the parenchyma includes the alveolus and tissue connected to and surrounding the cartilage that supports the larger airways.
- the parenchyma provides a tissue network which connects to and helps to support the airway. Edema or accumulation of fluid in lung tissue in asthmatic patients is believed to decouple the airway from the parenchyma reducing the restraining force of the parenchyma which opposes airway constriction.
- Application of therapeutic energy can be used to treat the parenchyma to reduce edema and/or improve parenchymal tethering.
- the applied energy may be used to improve connection between the airway smooth muscle and submucosal layer to the surrounding cartilage, and to encourage wound healing, collagen deposition, and/or fibrosis in the tissue surrounding the airway to help support the airway and prevent airway contraction.
- Airway diameter in asthmatic patients is reduced due to hypertrophy of the smooth muscle, chronic inflammation of the airway tissues, and general thickening of all parts of the airway wall.
- the overall airway diameter can be increased by a variety of techniques to improve the passage of air through the airways.
- Application of energy to the airway smooth muscle of an asthmatic patient can be used to debulk or reduce the volume of smooth muscle. This reduced volume of smooth muscle increases the airway diameter for improved air exchange.
- the airway diameter can also be increased by reducing inflammation and edema of the tissue surrounding the airway. Inflammation and edema (accumulation of fluid) of the airway occur in an asthmatic patient due to irritation.
- the inflammation and edema can be reduced by application of energy to stimulate wound healing and regenerate normal tissue.
- Healing of the epithelium or sections of the epithelium experiencing ongoing denudation and renewal allows regeneration of healthy epithelium with less associated airway inflammation.
- the less inflamed airway has an increased airway diameter both at a resting state and in constriction.
- the wound healing can also deposit collagen which improves parenchymal tethering.
- Inflammatory mediators released by tissue in the airway wall may serve as a stimulus for airway smooth muscle contraction. Smooth muscle contraction, inflammation, and edema can be reduced by a therapy which reduces the production and release of inflammatory mediators.
- inflammatory mediators are cytokines, chemokines, and histamine.
- the tissues which produce and release inflammatory mediators include airway smooth muscle, epithelium, and mast cells. Treatment of these structures with energy can reduce the ability of the airway structures to produce or release inflammatory mediators. The reduction in released inflammatory mediators will reduce chronic inflammation, thereby increasing the airway inner diameter, and may also reduce hyper-responsiveness of the airway smooth muscle.
- a further process for increasing the airway diameter is by denervation.
- a resting tone of smooth muscle is nerve regulated by release of catecholamines.
- Excess mucus production and mucus plugging are common problems during both acute asthma exacerbation and in chronic asthma management.
- Excess mucus in the airways increases the resistance to airflow through the airways by physically blocking all or part of the airway.
- Excess mucus may also contribute to increased numbers of leukocytes found in airways of asthmatic patients by trapping leukocytes. Thus, excess mucus can increase chronic inflammation of the airways.
- One type of asthma therapy involves treatment of the airways with energy to target and reduce the amount mucus producing cells and glands and to reduce the effectiveness of the remaining mucus producing cells and glands.
- the treatment can eliminate all or a portion of the mucus producing cells and glands, can prevent the cells from replicating or can inhibit their ability to secrete mucus. This treatment will have both chronic benefits in increasing airflow through the airways and will lessen the severity of acute exacerbations.
- each of the treatment devices described below can be modified to deliver or to remove energy in different patterns depending on the treatment to be performed.
- the treatment devices may be actuated continuously for a predetermined period while stationary, may be pulsed, may be actuated multiple times as they are moved along an airway, may be operated continuously while moving the device in an airway to achieve a “painting” of the airway, or may be actuated in a combination of any of these techniques.
- the particular energy application pattern desired can be achieved by configuring the treatment device itself or by moving the treatment device to different desired treatment locations in the airway.
- the treatment of an airway with the treatment device may involve placing a visualization system such as an endoscope or bronchoscope into the airways.
- the treatment device is then inserted through or next to the bronchoscope or endoscope while visualizing the airways.
- the visualization system may be built directly into the treatment device using fiber optic imaging and lenses or a CCD and lens arranged at the distal portion of the treatment device.
- the treatment device may also be positioned using radiographic visualization such as fluoroscopy or other external visualization means.
- the treatment device which has been positioned with a distal end within an airway to be treated is energized so that energy is applied to the tissue of the airway walls in a desired pattern and intensity.
- the distal end of the treatment device may be moved through the airway in a uniform painting like motion to expose the entire length of an airway to be treated to the energy.
- the treatment device may be passed axially along the airway one or more times to achieve adequate treatment.
- the “painting-like” motion used to exposed the entire length of an airway to the energy may be performed by moving the entire treatment device from the proximal end either manually or by motor. Alternatively, segments, stripes, rings or other treatment patterns may be used.
- the energy is transferred to or from an airway wall in the opening region of the airway, preferably within a length of approximately two times the airway diameter or less, and to wall regions of airways distal to bifurcations and side branches, preferably within a distance of approximately twice the airway diameter or less.
- the invention may also be used to treat long segments of un-bifurcated airway.
- One such treatment alters the structure of the airway, such as by reducing the amount of airway tissue.
- the addition of energy to the airway tissue may cause the DNA of the muscle cells to become cross linked.
- the smooth muscle cells with cross linked DNA cannot replicate.
- Another treatment alters the function of the airway, such as by reducing smooth muscle contraction, mucus gland secretions, or disrupting the inflammatory response.
- These treatments can be performed by applying energy of different types and in different patterns to achieve the desired results. In such cases, stiffness of the airway is increased as the energy induces a fibrosis or wound healing response that causes trauma to the airway wall.
- FIGS. 1 and 2 illustrate cross sections of two different airways in a healthy patient.
- the airway of FIG. 1 is a medium sized bronchus having an airway diameter D 1 of about 3 mm.
- FIG. 2 shows a section through a bronchiole having an airway diameter D 2 of about 1.5 mm.
- Each airway includes a folded inner surface or epithelium 10 surrounded by stroma 12 and smooth muscle tissue 14 .
- the larger airways including the bronchus shown in FIG. 1 also have mucous glands 16 and cartilage 18 surrounding the smooth muscle tissue 14 . Nerve fibers 20 and blood vessels 22 also surround the airway.
- FIG. 3 illustrates the bronchus of FIG. 1 in which the smooth muscle 14 has hypertrophied and increased in thickness causing the airway diameter to be reduced from the diameter D 1 to a diameter D 3 .
- FIG. 4 is a schematic side view of the lungs being treated with an energy transferring apparatus 30 according to the present invention.
- the device 30 is an elongated member for facilitating exchanging energy with a mass of airway tissue at a treatment site 34 within the lungs.
- the device 30 must be of a size to access the bronchus or bronchioles of the human lung.
- the device may be sized to fit within bronchoscopes, preferably, with bronchoscopes having a working channel of 2 mm or less. Also, the device should be of sufficient stiffness to fit and operate through the seal covering the working channel a bronchoscope.
- the energy may be delivered by the treatment device 30 in a variety of treatment patterns to achieve a desired response. Examples of patterns are discussed in further detail below.
- the energy which is delivered by the treatment device 30 may be any of a variety of types of energy including, but not limited to, radiant, laser, radio frequency, microwave, heat energy, or mechanical energy (such as in the form of cutting or mechanical dilation).
- the device may, but is not necessarily, configured to deliver energy in non-intersecting strip patterns which are parallel with a central axis of an airway.
- the device may be configured to deliver energy in a torsional pattern, or in a circumferential pattern around a wall of the airway.
- Such configurations which may be determined to deliver energy to the airway tissue that maximize the ability of the airway to permit airflow are considered to be within the scope of this invention.
- the inventive devices include tissue contacting electrodes configured to be placed within the airway. These devices can be used for delivering radio frequency in either a monopolar or a bipolar manner or for delivering other energy to the tissue, such as conducted heat energy from resistively heated elements.
- tissue contacting electrodes configured to be placed within the airway. These devices can be used for delivering radio frequency in either a monopolar or a bipolar manner or for delivering other energy to the tissue, such as conducted heat energy from resistively heated elements.
- monopolar energy delivery one or more electrodes of the treatment device are connected to a single pole of the energy source 32 and an optional external electrode 44 is connected to an opposite pole of the energy source.
- bipolar energy delivery multiple electrodes are connected to opposite poles of the energy source 32 and the external electrode 44 is omitted.
- the external electrode 44 depicted in FIG. 4 is not required in the case of bipolar energy delivery.
- the number and arrangement of the electrodes may vary depending on the pattern of energy delivery desired.
- the treatment devices of FIGS. 5A-10 , and 12 - 20 are used to deliver radiant or heat energy to the airway.
- the treatment device of FIG. 11 may also be used to deliver indirect radio frequency, microwave energy, or conductive heat energy to the tissue.
- the current may be AC or DC current or in the case of AC, the current may be delivered in the RF range.
- the use of RF provides an added safety feature of minimizing the possibility of harm to the patient caused by escaped current.
- the device may also use a combination of any of the energy transferring element configurations described herein.
- the treatment device 302 of FIG. 5A includes an elongated member 102 for delivering an expandable member 104 to a treatment site.
- the expandable member 104 may have a plurality of energy transfer elements (not illustrated) which are placed on a plurality of basket legs 106 to transfer energy at the treatment site.
- the expandable member comprises a basket 104 which is defined by a number of basket legs 106 .
- the basket legs 106 are formed from a plurality of elements which are soldered or otherwise connected together at two connection areas, a proximal joint 108 and a distal joint 110 .
- a desirable length of the basket 104 depends upon numerous factors.
- One consideration in determining a desired length of the expandable member, e.g., the distance between the joints of the basket, of the inventive device is related to the dimension of the target area or treatment region. For instance, some other factors include considerations of minimizing the amount of the expandable portion which is distal to the treatment region for optimized access, minimizing the amount of the expandable portion that is proximal to the treatment region for visualization and access concerns, and setting a desirable length of the expandable portion that will contact a sufficient portion of the treatment region during each application of the device.
- a compromise of such factors along with other considerations provides a desirable length for the expandable portion of the device.
- the distance between the distal and proximal joints of the basket is less than 35 mm when the basket is in a first unexpanded state.
- the legs 106 may be selected from a material that allows the basket to expand without plastic deformation.
- the legs may comprise a stainless steel, or a shape memory/superelastic alloy such as a nitinol material.
- the basket legs 106 may have a rectangular cross section in those variations where the legs 106 are formed from ribbons, or the legs 106 may have a circular cross section in those variations where the legs are formed from wires.
- the legs 106 may also have other cross section as desired. It is also contemplated that the legs 106 need not all have similar cross sections.
- the cross section of each of the legs 106 in a basket 104 may be individually chosen to optimize such factors as the resilience of the basket 104 , or to optimize energy transfer characteristics.
- the legs may also have a variable cross section along the length of the basket.
- the proximal 108 and/or distal 110 joints may also contain adhesive to bind the legs 106 .
- the basket legs 106 between the proximal 108 and distal joint 110 are formed into the basket shape 104 so that arch shaped portions of the basket legs 106 will contact the walls of an airway to facilitate energy transfer.
- the basket legs 106 may have a more oblong shape or sharper bends to allow for a more parallel leg surface area that contacts the target tissue.
- Each leg 106 may have a center that is substantially parallel to the elongated body so that there is sufficient contact between the airway walls and the parallel portion of the leg 106 . The center that is substantially parallel is usually referred to as the active region of the leg 106 .
- the length of the basket 104 between the proximal and distal 110 joints may be less than 35 mm when the basket 104 is in a first unexpanded state.
- the legs 106 may be coated with an insulating material (not shown) except at the tissue contact points.
- the legs 106 of the basket 104 may be exposed while the proximal 108 and distal joint 110 are insulated.
- the basket 104 is formed of a resilient material which allows the distal end of the inventive device 302 to be confined by a sheath (not shown) for delivery of the device 302 to the treatment site and allows the basket 104 to return to its original basket shape upon deployment.
- a variation of the invention is that the basket self-expands from a first state to a second expanded state upon the removal of any constraining or restrictive member such as a sheath (not shown).
- the inventive device 302 is preferably configured such that the basket legs 106 have sufficient resilience to come into contact with the airway walls for treatment.
- FIG. 5A further illustrates a variation of the inventive device 302 in which a distal end of the device 302 is provided with a distal tip 112 that can have a radius to facilitate insertion of the device 302 into the lungs and also to minimize the possibility of causing trauma to surrounding tissue.
- the tip 112 is preferably sized to prevent the gouging of airway by the sheath.
- the design of the distal tip is selected to be atraumatic.
- the size of the tip may be selected to be large enough to prevent the sheath from gouging airways yet small enough to pass in and out of a bronchoscope.
- FIG. 5B illustrates a variation of the inventive device 302 having basket legs 108 connected to a distal end 114 of the elongated member 102 and forming a basket 104 .
- a proximal joint is found at the distal end 114 of the elongated member 102 .
- the basket 104 is expanded radially, to its second state, during use to ensure contact between the energy transfer elements (not shown) and the airway walls (not shown) by, for example, pulling on a center pull wire 116 which is connected to a distal tip 118 of the expandable portion 104 .
- the center pull wire 116 may extend through a lumen of the elongated member 102 towards a proximal portion (not shown) of the elongated member 102 . It is also contemplated that the center pull wire 116 may be configured to deliver current to the energy transfer elements found on the expandable member 104 .
- the inventive device 302 may be delivered to a treatment site through a delivery sheath 120 and may be drawn along or moved axially along the airway to treat the airway in a pattern of longitudinal or helical stripes.
- the basket 104 may be resilient or self-expanding (e.g., see FIG. 5A ) to expand to a second expanded state or the basket 104 may require an expanding force (e.g., see FIG. 5B ).
- FIG. 5B An example of this variation of the inventive device 304 is shown in FIG. 5B .
- the basket 104 may be resilient and the sheath 120 may comprise the deployment member.
- the basket 104 contracts within the sheath 120 and assumes a first state.
- the basket 104 may resiliently assume a second expanded state.
- the basket 104 may assume a second expanded state with the aid of a wire 116 .
- This wire may also be configured to deliver power to the energy exchange elements 106 .
- FIG. 5C illustrates another variation of the inventive device where an elongated member 102 of is configured to have a plurality of lumens 140 so that each of the basket legs 106 are isolated within the lumens 140 of the elongated member 102 until the legs 106 exit the elongated member 102 and connect at a proximal joint 108 .
- the invention may have basket legs 106 selected with a sufficient length such that the ends of each of the legs 106 extend substantially into the lumens 140 . As a result of being inserted deeply within the lumen, the ends of the legs 106 would require significant travel before they exited the lumen 140 . This feature provides added safety as it minimizes the risk of the basket legs 106 dislodging from the elongate member 102 .
- the elongated member 102 may comprise concentric tubes (not shown) rather than multi-lumen tubes where basket legs are inserted in the annulus between the tubes. It is also contemplated that an elongated member may be reinforced with the use of a reinforcing member. Such a reinforcing member may include a coiled wire or polymeric insert.
- FIG. 5D-5I illustrate variations of the inventive device that use an expanding force to expand the basket.
- FIG. 5D illustrates a deployment member of the device.
- FIG. 5E illustrates the device of FIG. 5D when the elongated member is moved in a distal direction to a deployment point.
- FIG. 5F-5G illustrates the elongated member 102 , sheath 120 , expandable member 104 , distal tip 118 , and wire 122 extending through the device.
- FIG. 5F illustrates the basket 104 in a first unexpanded state when the elongated member 102 and wire 122 are proximal of the deployment point 130 .
- FIG. 5G illustrates the expansion of the basket 104 to a second expanded state as the elongated member 102 moves distally and the wire 122 is restrained at the deployment point 130 .
- the deployment member may comprise a handle 124 which is adjacent to a proximal portion of an elongated member 102 .
- the handle may be designed to be operated by a single hand, either right or left.
- the handle may also have a control switch for operation of the device. Such a switch could control the power supply attached to the device as well.
- the handle may be configured to determine the position of the device within a human body as the device is advanced to a target site. For example, marks on the handle or even a readout could provide information to the user as to the relative deployment state of the expandable member.
- a sensor may be placed on the handle 124 , this sensor may be used to determine the position of the expandable member.
- the handle 124 may control the expandable member using force compensation (e.g., a spring, etc.) or deflection limiting stops to control the expansion of the expandable member.
- force compensation e.g., a spring, etc.
- deflection limiting stops to control the expansion of the expandable member.
- an elongated member 102 may be slidably mounted to the handle.
- the variation of the invention depicted in these Figures may also, but does not necessarily, include a sheath 120 exterior to the elongated body 102 .
- a wire 122 extends from the handle through the elongated member 102 and may be attached to a distal tip 118 of the device.
- the wire 122 , elongated member 102 , and distal tip (not shown) are slidably moveable in both a distal and proximal directions.
- the handle may also include a stop 126 which prevents the wire 122 from moving distally beyond a deployment point 130 .
- the stop 126 may be connected to a spring (not shown) to limit the expansion of the expandable member upon reaching a pre-determined force.
- the handle 124 may include a control member 128 that is moveably attached to the handle 124 for moving the elongated member 102 in a distal/proximal direction.
- the handle 124 in the figures is depicted to have a control member 128 as illustrated, other variations of control members are also contemplated to be within the scope of this invention.
- a handle 124 may include other configurations, such as lever, thumb-wheel, screw-mechanism, ratchet mechanism, etc., which are attached to the handle 124 to provide control actuation for the expandable member.
- FIG. 5E illustrates a variation of the inventive device when the elongated member 102 and wire 122 are moved in a distal direction.
- a stop 126 prevents the wire 122 from moving distally of a deployment position 130 .
- This illustration further illustrates a variation of the invention where the stop 126 is attached to springs 127 which provide force compensation for the expandable member on the device.
- a control member 128 may have a stop which limits its travel along a handle 124 . Such a stop is an example of a deflection limiting mechanism which controls the movement of the control member 128 , thus controlling the extent of the expansion of the expandable member.
- FIG. 5F illustrates the invention when the expandable member or basket 104 is in a first unexpanded state.
- the wire 122 is attached to a distal tip 118 of the device and both are prevented from distal movement when the wire 122 is in the deployment position 130 . Therefore, as depicted in FIG. 5G , movement of the elongated member 102 in a distal direction against a distal tip 118 , that is restrained by a wire 122 , causes a basket 104 to compress between the advancing elongated member 102 and the stationary distal end 118 . Thus, the basket 104 is forced outward and radially expands into a second expanded state.
- the wire 122 may also be used to transfer energy to or from the energy transfer elements found on the basket 104 .
- the wire 122 may be a wire, a ribbon, a tube, or of any other equivalent structure.
- a detent means for maintaining the elongated member in a distal position to expand the basket 104 against the distal tip 118 without the need for continual applied force by a user of the device.
- a ratchet member, or friction member to maintain the basket 104 in the expanded state.
- FIG. 5H illustrates another variation of a deployment member.
- a sheath 120 may be slidably attached to a handle 124 .
- the elongate member 102 is rigidly attached to the handle 124 .
- the sheath 120 may be attached to a first control member 129 .
- a wire 122 extends through the elongate member 102 and is attached to the distal tip of the device (not shown).
- the wire 122 may be attached to a second control member 131 .
- proximal movement of the first control member 129 causes the sheath 120 to proximally retract over the elongate member 102 and uncover the expandable portion (not shown).
- Proximal movement of the second control member 131 causes the wire 122 , distal joint, and expandable member to move against the non-moving elongate member 102 which causes the expandable member to expand into a second state.
- FIG. 5J-5L illustrate examples of energy transfer elements that may be located on the expandable portion of the device.
- the basket legs 106 may function as heat exchange elements.
- the device may be configured so that the leg is an electrode or the conductive heating element.
- the leg 106 may be partially covered with an insulation only leaving an active region exposed for delivery of energy to the airways. Examples of such insulation include a heat shrink sleeve, a dielectric polymeric coating, or other material which may function as an insulator.
- FIG. 5J illustrates an example of a basket leg 106 with an energy transferring element 132 coiled around the leg 106 .
- the energy transferring element uses conductive heating and comprises a resistance heating element 132 coiled around the leg 106 .
- FIG. 5K illustrates a variation of the invention having an RF electrode attached to the basket leg 106 .
- the RF electrode may be attached to the basket leg 106 via the use of a fastener 134 .
- the electrode may be attached via the use of a heat shrink fastener 134 , (e.g., polymeric material such as PET or polyethylene tubing).
- FIG. 5L illustrates another variation of the invention where the energy transfer element is a printed circuit 138 that is situated around the leg 106 and secured to the leg.
- energy transfer elements are a polymeric heating material, an electrically conductive paint, a resistance element sputtered onto the leg in a pattern or formed on a substrate by photofabrication.
- the basket leg itself may be chosen of appropriate size and resistivity to alloy dual use as a basket and energy transfer element. Many nickel-chromium alloys have both high specific resistance and significant spring-like properties.
- adhesives or other coatings may also be used to secure the energy transfer element to the basket leg 106 .
- the energy transfer elements are not limited to what is illustrated in the drawings. It is also contemplated that other types of energy transferelements may be used such as radiant, laser, microwave, and heat energy.
- FIG. 6A illustrates a variation of a distal tip 210 having a redundant joint.
- the distal tip 208 has a polymeric cap 210 covering the distal ends of the basket legs 106 and wire 212 .
- the legs 106 are soldered 214 to the distal end of the wire 212 .
- Also used to maintain the joint is an adhesive 216 substantially filling the polymeric cap 210 .
- a multi-lumen piece 218 separates the legs 106 and wire 212 .
- a side view of the multi-lumen piece 218 is shown in FIG. 6B .
- a multi-lumen tubing may be used for the multi-lumen piece 218 .
- the ends 220 of the polymeric cap 210 may be heat formed or otherwise tapered down around the legs 106 .
- FIG. 6C illustrates another variation of a distal tip 222 having a redundant joint.
- the distal tip 222 has a polymeric cap 210 covering the distal ends of the basket legs 106 and wire 212 .
- the legs 106 are soldered 214 to the distal end of the wire 212 .
- Also used to maintain the joint is an adhesive 216 substantially filling the polymeric cap 210 .
- a hypo-tube 224 covers the legs 106 and wire 212 .
- a side view of the hypo-tube 224 is shown in FIG. 6D .
- the distal end of the hypo-tube 224 may be flared to seat a ball located on a distal end of the wire 212 and the legs 106 .
- a proximal end of the hypo-tube 224 may be flared to provide greater interlock with ends 220 of the polymeric cap 210 .
- the ends of the legs 106 taper outwards from the hypo-tube 224 and form an area with a diameter larger than the end of the cap 226 which may be tapered down around the legs 106 and wire 212 .
- the ends 220 of the polymeric cap 210 may be heat formed or otherwise tapered down.
- FIG. 6E shows another variation of the invention having a hoop or ring 228 at a proximal joint of the device.
- the hoop 228 may be soldered or welded to the legs 106 and keeps the legs 106 attached even if a joint fails between the legs and the elongate member 102 . Also, the hoop 228 may electrically connect the legs, preventing disconnection of single leg 106 having a temperature sensing element attached.
- the invention also includes a temperature detecting element (not shown).
- temperature detecting elements include thermocouples, infrared sensors, thermistors, resistance temperature detectors (RTDs), or any other apparatus capable of detecting temperatures or changes in temperature.
- the temperature detecting element is preferably placed in proximity to the expandable member.
- a temperature sensor may be mounted along the pull wire 116 .
- a temperature sensor may be mounted between the energy transfer elements 132 , 136 , 138 and the leg 106 .
- a temperature sensor is placed on a single basket leg 106 to provide a signal to control energy transfer.
- a temperature sensor may be placed on more than one basket leg 106 , and/or on a central wire 116 to provide control for multiple areas of energy transfer.
- the temperature sensor may be placed on the inside of the basket leg 106 to protect the temperature sensor while still providing a position advantageous to determining the device temperature at the energy transfer element.
- FIG. 5M illustrates a variation of the invention having thermocouple leads 139 attached to a leg 106 of the device.
- the leads may be soldered, welded, or otherwise attached to the leg 106 .
- This variation of the invention shows both leads 139 of the thermocouple 137 attached in electrical communication to a leg 106 at separate joints 141 .
- the temperature sensor is at the surface of the leg.
- This variation provides in case either joint becomes detached, the circuit will be open and the thermocouple 137 stops reading temperature.
- the device may also include both of the thermocouple leads as having the same joint.
- FIG. 7A-7D illustrate variations of the device in which impedance may be varied by wiring the basket legs 106 in series or in parallel.
- FIG. 7A illustrates a series wiring diagram in which a current path 142 flows from a first leg to a second leg 106 , a third leg 106 , and a fourth leg 106 sequentially.
- FIG. 7B illustrates the series wiring diagram and shows a single wire 143 connecting the legs 106 in series.
- the wire 143 may, for example, extend to a distal end of the leg and wrap over itself to the proximal end of the leg 106 .
- a covering (not shown) may be placed over the wire 143 wrapped leg 106 at the proximal end of the device.
- FIG. 7C illustrates another variation of a series wiring diagram.
- a wire 143 extends from the proximal end of a leg 106 to its distal end and then extends to the distal end of an adjacent leg 106 and extends back to the proximal end
- FIG. 7D illustrates a parallel wiring diagram in which a current path 142 flows to each leg 106 .
- Series wiring has an added advantage in that all current will pass through each energy transfer element. By design, this configuration equalizes the heat dissipated at each leg through construction of legs with equal resistance. In addition, in the event of failure of any electrical connection, no energy is delivered. This provides an additional safety feature over parallel wiring.
- the electrical current may be AC or DC.
- AC may be delivered in the RF range as a safety measure additional to electrical isolation.
- DC may be used to allow a portable device powered by a battery pack or provide an energy source within the device itself.
- FIG. 8A-8C illustrates variation of the legs 106 of the basket 104 .
- the legs may, for example, comprise a stainless steel, or a shape memory/superelastic alloy such as a nitinol material.
- the basket legs 106 may have a rectangular cross section in those variations where the legs 106 are formed from ribbons, or the legs 106 may have a circular cross section in variations where the legs 106 are formed from wires.
- a leg 106 may be configured to have a non-axisymmetric cross-section. For example, the leg may have an oval or flat cross section as well.
- the legs 106 of a basket 104 need not all have similar cross sections.
- each of the legs 106 in a basket 104 may be individually chosen to optimize such factors as the resilience of the basket 104 , or to optimize energy transfer characteristics.
- FIG. 8A illustrates a top view of a basket leg 106 that has a contoured shape 144 .
- the energy exchange element is not shown in the figure for clarity.
- FIG. 8B One of the purposes of such a contoured shape 144 is illustrated in FIG. 8B .
- leg 106 is configured to bend at or substantially near to points 146 .
- a benefit of such a configuration is to allow a substantially parallel active surface as defined by the contour shape 144 .
- the leg 106 has a region of increased diameter 148 in the case of round wire, or increased width or thickness in the case of rectangular or other non-axisymmetric wire.
- a region 106 could also be a flat wire with bumps or protrusions creating areas of increased width of the flat wire.
- This region 148 may, for example, provide a stop that assists in locating insulation, heat shrink, or other external covering around the leg 106 .
- a leg 106 that consists of a composite construction.
- the leg 106 may comprise of differing materials in predetermined regions to control the bending of the leg 106 as the basket 104 expands, or the leg may be constructed of different materials to selectively control regions of deliver of energy on the leg.
- FIG. 9A-9D illustrates another variation of the inventive device in which the expandable member comprises basket from a single piece or sheet of material. Such a configuration could comprise an etched, machined, laser cut, or otherwise manufactured piece of metal.
- FIG. 9A illustrates a partial view of a basket 104 formed from a single piece of material. The thickness of the material is, for example 0.005 inches but may vary as desired.
- the illustration of FIG. 9A shows the basket 104 prior to being wrapped about the Z direction as indicated. As shown, the legs 106 may be of varying length or they may be the same length 106 or a combination thereof.
- the basket 104 may have a distal portion 164 or basket head 164 which may be configured to facilitate construction of the device.
- the basket head 164 may be notched 166 to obtain a desired shape as the basket is wrapped about the Z direction.
- FIG. 9B illustrates a variation of the basket head 165 being notched such that sections 165 of the material may be bent from the plane of the material to form tabs 165 .
- Tabs 165 may be used to form mechanical joints with another part, such as a distal tip cap.
- FIG. 9C illustrates another variation of a basket 104 made from a single piece of material.
- the legs 106 of the basket 104 are bent in a direction orthogonal to the plane of the basket head 164 .
- the distance between the ends of the legs 106 may be, for example, about 2.75 inches.
- FIG. 9D illustrates a variation of the proximal ends of the legs 106 of the basket 104 .
- the proximal ends of the legs 106 may have features 168 which promote the structural integrity of the proximal joint (not shown) of the device.
- the ends of the legs 106 have a saw-tooth design which improve the integrity of the proximal joint connecting the legs 106 to the elongated member.
- the variation of FIG. 9D also illustrates a proximal end of the leg 106 as having a radius, however, the end of the leg 106 may have other configurations as required.
- the legs 106 may have a width of, for example, 0.012 inches and a separation of, for example, 0.016 inches. However, these dimensions may vary as needed.
- FIG. 10 illustrates another variation of the inventive device 306 in which the expandable member comprises a balloon member 150 .
- This variation of the device 306 includes electrodes 154 positioned on an exterior surface of the balloon member 150 .
- the electrodes 154 may be connected to an energy source (not shown) by leads 156 extending through the balloon and through the lumen of an elongated member 102 .
- the balloon member 150 may be filled with a fluid 152 such as saline or air to bring the electrodes 154 into contact with the airway wall 10 .
- the electrodes may also be resistance heating elements, RF electrodes, or another suitable element for conducting energy transfer with the airway.
- a single electrode may continuously surround a circumference of a balloon 150 , or a plurality of electrodes may be spaced at certain intervals to substantially surround the circumference of a balloon 150 .
- FIG. 11 illustrates another variation of the inventive device 308 in which the expandable member comprises a balloon member 150 in which a fluid 152 within the balloon member 150 is heated by a heat generating element 158 .
- the heat generating elements 158 are illustrated in the shape of coils surrounding the shaft of the elongated member 102 , however other types of heat generating elements (not shown) shapes may also be used.
- the heat generating elements 154 may be used as resistance heaters by application of an electric current to the heat generating elements. Alternatively, radio frequency or microwave energy may be applied to the heat generating elements 158 to heat fluid 152 within the balloon member 150 .
- the fluid may be configured to optimize conductive heat transfer from the electrodes 158 to the exterior of the balloon member 150 .
- Radio frequency or microwave energy may also be applied indirectly to the airway wall through the fluid and the balloon.
- hot fluid may be transmitted to the balloon member 150 from an external heating device for conductive heating of the airway tissue.
- FIG. 12 Another variation of the inventive device 310 is illustrated in FIG. 12 includes a plurality of energy transfer elements 162 positioned on pre-shaped tines 160 .
- the pre-shaped tines 160 may be outwardly biased such that they expand from a first shape inside sheath 120 into a second expanded shape once advanced out of sheath 120 .
- the tines 160 may also be configured so that they retract into a first state once withdrawn into a sheath 120 .
- the pre-shaped tines 160 may be connected to an elongate member 102 which is positioned within a sheath 120 .
- the pre-shaped tines 160 and the energy transfer elements 162 may be delivered through a delivery sheath 120 to a treatment site within the airways. When the pre-shaped tines 160 exit a distal end of the sheath 120 , the pre-shaped tines 160 may bend outward until the energy transfer elements 162 come into contact with the airway walls for transfer of energy with the airway walls.
- FIG. 13 illustrates a variation of the inventive device 314 in which a elongated member 102 is provided with a plurality of energy transfer elements 170 positioned on at least one inflatable balloon 172 .
- the energy transfer elements 170 may be RF electrodes or resistance heating elements.
- the balloons 172 are inflated through the elongated member 102 to cause the energy transfer elements 170 to come into contact with the airway walls 10 .
- the energy transfer elements 170 are preferably connected to the energy source (not shown) by conductive wires (not shown) which extend from the energy transfer elements 170 through or along the balloons 172 and through the elongated member 102 to the energy source.
- the electrodes 170 may be used in a bipolar mode without an external electrode.
- the inventive device 314 may be operated in a monopolar mode with an external electrode (not shown, see FIG. 4 ).
- Another variation of the invention includes using resistance heating elements as the energy transfer elements 170 .
- the energy transfer elements 170 may be a single continuous circular element or there may be a plurality of elements 170 spaced around the balloons 172 .
- An alternative of the inventive device 316 of FIG. 14 includes an elongated member 102 having one or more grooves 174 in an exterior surface. Positioned within the grooves 174 are electrodes 176 for delivery of energy to the airway walls. Although the grooves 174 have been illustrated in a longitudinal pattern, the grooves may be easily configured in any desired pattern.
- the inventive device 316 of FIG. 14 includes a biasing member (not shown) for biasing the elongated member 102 against an airway wall such that the electrodes 176 contact airway tissue.
- the biasing member may be a spring element, an inflatable balloon element, or other biasing member.
- the biasing function may be performed by providing a preformed curve in the elongated member 102 which causes the device to curve into contact with the airway wall when extended from a delivery sheath (not shown).
- FIG. 15 illustrates a variation of the inventive device 318 having one or more electrodes 178 connected to a distal end of an elongated tube 102 .
- the electrodes 178 are supported between the distal end of the elongated tube 102 and a distal tip 180 .
- a connecting shaft 182 supports the tip 180 .
- Also connected between the distal end of the elongated member 102 and the distal tip 180 is a spring element 184 for biasing the electrodes 178 against a wall of the airway.
- the spring element 184 may have one end which slides in a track or groove in the elongated member 102 such that the spring 184 can flex to a variety of different positions depending on an internal diameter of the airway to be treated.
- FIG. 16 illustrates an alternative of the inventive device 320 in which the one or more electrodes 186 are positioned on a body 188 secured to an end of an elongated member 102 .
- the body 188 is illustrated as egg shaped, however, other body shapes may also be used.
- the electrodes 186 extend through holes 190 in the body 188 and along the body surface.
- a biasing member such as a spring element 184 is preferably provided on the body 188 for biasing the body with the electrodes 186 against the airway walls.
- Leads 192 are connected to the electrodes 186 and extend through the elongated member 102 to the energy source not shown.
- FIGS. 17 and 18 illustrate embodiments of the invention 322 , 324 in which electrodes 194 in the form of wires are positioned in one or more lumens 196 of an elongated member 102 . Openings 198 are formed in side walls of the elongated member 102 to expose the electrodes 194 to the surrounding tissue.
- the inventive device 322 may have multiple lumens 196 with electrodes 194 provided in each of the lumens 196 .
- the side wall of the inventive device 322 is cut away to expose one or more of the electrodes 194 through a side wall opening 198 .
- the opening 198 exposes two electrodes 194 positioned in adjacent lumens.
- the inventive device 322 may be provided with a biasing member as discussed above to bring the electrodes 195 of the device into contact with the airway wall.
- FIG. 18 Another variation of the inventive device 324 as shown in FIG. 18 includes an elongated member 102 which has an expandable loop shaped member 202 to allow the electrodes 194 to be exposed on opposite sides of the device 324 which contacts opposite sides of the airway.
- the resilience of the loop shaped member 202 causes the electrodes 194 to come into contact with the airway walls.
- FIGS. 19 and 20 illustrate a further variation of the inventive device 326 having an expandable member 204 in a first non-expanded state and in a second expanded state.
- FIG. 19 illustrates the device as having one or more loop shaped electrodes 204 connected to an elongated member 102 .
- the loop of the electrode 204 lies along the sides of a central core 206 .
- a distal tip of the loop electrode 204 is secured to the core 206 and to a distal tip 208 .
- the core 206 may be slidable in a lumen of the elongated member 102 .
- the electrode 204 is expanded by pulling the core 206 proximally with respect to the elongated member 102 , as shown in FIG. 20 .
- the electrode 204 or the core 206 may be spring biased to return to a configuration of FIG. 20 when a constraining force is removed. This constraining force may be applied by a delivery sheath or bronchoscope through which the inventive device 326 is inserted or by a releasable catch.
- the treatment of the tissue in the airway walls by transfer of energy according to the present invention provides improved long term relief from asthma symptoms for some asthma sufferers.
- some amount of smooth muscle or mucus gland cells which were not affected by an initial treatment may regenerate and treatment may have to be repeated after a period of time such as one or more months or years.
- the airways which are treated with the device according to the present invention are preferably 1 mm in diameter or greater, more preferably 3 mm in diameter.
- the devices are preferably used to treat airways of the second to eighth generation, more preferably airways of the second to sixth generation.
- the present invention has been described in detail with respect to devices for the treatment of airways in the lungs, it should be understood that the present invention may also be used for treatment of other body conduits.
- the treatment system may be used for reducing smooth muscle and spasms of the esophagus of patients with achalasia or esophageal spasm, in coronary arteries of patients with Printzmetal's angina variant, for ureteral spasm, for urethral spasm, and irritable bowel disorders.
- the devices and method describe herein provide a more effective and/or permanent treatment for asthma than the currently used bronchodilating drugs, drugs for reducing mucus secretion, and drugs for decreasing inflammation.
- the inventive device may also include a steering member configured to guide the device to a desired target location.
- this steering member may deflect a distal tip of the device in a desired direction to navigate to a desired bronchi or bronchiole.
- a vision system may comprise a fiber optic cable which allows a user of the device to guide a distal tip of the device to its desired location.
- the vision system may include a CCD chip.
- a power supply for providing energy as described above.
- the power supply provides the energy to be delivered to airway tissue via the energy transfer device. While the main goal of the power supply is to deliver enough energy to produce the desired effect, the power supply must also deliver the energy for a sufficient duration such that the effect persists. This is accomplished by a time setting which may be entered into the power supply memory by a user.
- a power supply may also include circuitry for monitoring parameters of energy transfer: (for example, voltage, current, power, impedance, as well as temperature from the temperature sensing element), and use this information to control the amount of energy delivered.
- parameters of energy transfer for example, voltage, current, power, impedance, as well as temperature from the temperature sensing element
- a power supply may also include control modes for delivering energy safely and effectively. Energy may be delivered in open loop power control mode for a specific time duration. Energy may also be delivered in temperature control mode, with output power varied to maintain a certain temperature for a specific time duration. In the case of RF energy delivery via RF electrodes, the power supply may operate in impedance control mode.
- the power supply will operate at up to a 75° C. setting.
- the duration must be long enough to produce the desired effect, but as short as possible to allow treatment of all of the desired target airways within a lung. For example, 5 to 10 seconds per activation (while the device is stationary) is preferred. Shorter duration with higher temperature will also produce acceptable acute effect.
- the power supply may include control algorithms to limit excessive thermal damage to the airway tissue. For example, in order to stop delivery of energy in the event of contact between airway tissue and device legs having temperature sensing capabilities, an algorithm may be employed to shut down energy delivery if the sensed temperature does not rise by a certain number of degrees in a pre-specified amount of time after energy delivery begins.
- Another way to stop energy delivery includes shutting down a power supply if the temperature ramp is not within a predefined rage at any time during energy delivery.
- Other algorithms include shutting down a power supply if a maximum temperature setting is exceeded or shutting down a power supply if the sensed temperature suddenly changes, such a change includes either a drop or rise, this change may indicate failure of the temperature sensing element.
- a variation of the invention includes configuring each energy exchange element independently to provide selective energy transfer radially about the device.
- another variation of the invention includes providing feedback control to determine the impedance of the airway to determine the power required by a power supply. Again, as discussed above, the feedback control could also be used to determine the size of the airway in which the device is positioned.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Otolaryngology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- Surgical Instruments (AREA)
Abstract
Description
- This is a Continuation-in-part application of U.S. application Ser. No. 09/296,040 filed Apr. 21, 1999, and of Continuation-in-part U.S. application Ser. No. 09/095,323 filed Jun. 10, 1998 both of which applications are incorporated herein by reference in their entirety.
- 1. Field of the Invention
- The invention relates to a device for treating lung disease, and more particularly, the invention relates to a device for transferring energy into airway tissue such as that found in the airways of human lungs. This includes heating and applying RF energy to the airway. In the airways of the lung, the transfer of energy into the airway tissue stiffens that tissue or reduces the ability of the airways to constrict. In general the treatment reduces the resistance to the flow of air through the airway.
- 2. Brief Description of the Related Art
- Asthma is a disease in which (i) bronchoconstriction, (ii) excessive mucus production, and (iii) inflammation and swelling of airways occur, causing widespread but variable airflow obstruction thereby making it difficult for the asthma sufferer to breathe. Asthma is a chronic disorder, primarily characterized by persistent airway inflammation. However, asthma is further characterized by acute episodes of additional airway narrowing via contraction of hyper-responsive airway smooth muscle.
- Asthma stimuli may be allergenic or non-allergenic. Examples of allergenic stimuli include pollen, pet dander, dust mites, bacterial or viral infection, mold, dust, or airborne pollutants; non-allergenic stimuli include exercise or exposure to cold, dry air.
- In asthma, chronic inflammatory processes in the airway play a central role. Many cells and cellular elements are involved in the inflammatory process, particularly mast cells, eosinophils T lymphocytes, neutrophils, epithelial cells, and even airway smooth muscle itself. The reactions of these cells result in an associated increase in the existing sensitivity and hyperresponsiveness of the airway smooth muscle cells that line the airways to the particular stimuli involved.
- The chronic nature of asthma can also lead to remodeling of the airway wall (i.e., structural changes such as thickening or edema) which can further affect the function of the airway wall and influence airway hyperresponsiveness. Other physiologic changes associated with asthma include excess mucus production, and if the asthma is severe, mucus plugging, as well as ongoing epithelial denudation and repair. Epithelial denudation exposes the underlying tissue to substances that would not normally come in contact with them, further reinforcing the cycle of cellular damage and inflammatory response.
- In susceptible individuals, asthma symptoms include recurrent episodes of shortness of breath (dyspnea), wheezing, chest tightness, and cough. Currently, asthma is managed by a combination of stimulus avoidance and pharmacology.
- Stimulus avoidance is accomplished via systematic identification and minimization of contact with each type of stimuli. It may, however, be impractical and not always helpful to avoid all potential stimuli.
- Asthma is managed pharmacologically by: (1) long term control through use of anti-inflammatories and long-acting bronchodilators and (2) short term management of acute exacerbations through use of short-acting bronchodilators. Both approaches require repeated and regular use of the prescribed drugs. High doses of corticosteroid anti-inflammatory drugs can have serious side effects that require careful management. In addition, some patients are resistant to steroid treatment. Patient compliance with pharmacologic management and stimulus avoidance is often a barrier to successful asthma management.
- Asthma is a serious disease with growing numbers of sufferers. Current management techniques are neither completely successful nor free from side effects.
- Accordingly, it would be desirable to provide an asthma treatment which improves airflow without the need for patient compliance.
- In addition to the airways of the lungs, other body conduits such as the esophagus, ureter, urethra, and coronary arteries, are also subject to periodic spasms that interfere with their normal function.
- The present invention relates to a device for treating airway tissue within the lungs by transfer of energy into the walls of the airway to reduce plugging of the airway, to prevent the airway from being able to constrict, to increase the inner airway diameter, or to reduce resistance to flow through the airway. The invention is particularly directed to the treatment of the airways in the lungs to reduce the effects of asthma and other lung disease. One variation of the invention includes the transfer of energy to the airway wall via the application of heat.
- The present invention provides devices to decrease airway responsiveness and airway resistance to flow which may augment or replace current management techniques. In accordance with one variation of the present invention, an energy transfer apparatus for treating conditions of the lungs by decreasing airway responsiveness includes transferring energy into an airway wall to alter the airway wall in such a manner that the responsiveness of the airway is reduced.
- In particular, the inventive device is an energy transfer apparatus which facilitates energy transfer with a mass of tissue within the airways of a lung. The inventive device is sized to enter the bronchus or bronchiole of a human lung to conduct energy transfer with the airway tissue therein. The inventive device may also be sized to fit within a bronchoscope. The bronchoscope may have a channel with a diameter of preferably 2 mm or less.
- A variation of the inventive device includes a flexible elongated body having a proximal portion and a distal portion with a lumen extending between the proximal and distal portions. The flexible elongated body may be of sufficient stiffness to pass through a seal of a working channel of a bronchoscope and allow operation of the device through the working channel seal. The device may include an expandable portion that is adjacent to a distal portion of the elongated body. The expandable portion has a first state, e.g., a size, and a second state where the second state is radially expanded in size from the elongated body. The device may include a temperature detecting element which is placed near to the expandable portion. The device also includes at least one energy transfer element at an exterior of the expandable portion, where the energy transfer elements are configured to contact the wall of the bronchus or bronchiole when the expanded portion is in an expanded state. The device may also include a deployment member that is configured to move the expandable portion between the first and second radially expanded states. The deployment member may extend between the expandable portion and the proximal portion of the elongated body. The inventive device may further include a distal tip located at a distal end of the apparatus. One variation of the inventive device includes an expandable portion that has a diameter of less than 15 mm when in a second expanded state.
- Another variation of the invention includes an expandable portion which includes pre-shaped tines. Such tines are configured to be in a first state within an elongated body and, when advanced out of the elongated body, to expand into a second expanded state. The tines may be connected to each other with an expanding element to prevent the tines from entering multiple airways at a bifurcation.
- Another variation of the invention includes an expandable portion comprised of a balloon. This variation of the invention may include the use of a fluid which may expand the balloon into the second state. Yet another variation of this invention includes the use of a heat generating element in the balloon which conducts heat to the fluid to heat an exterior of the balloon. In this variation, the exterior of the balloon serves as the energy transfer element.
- A further variation of the inventive device includes an expandable portion which comprises a plurality of legs which forms a basket. The legs of this variation may extend from a proximal joint that is found at an intersection of a distal portion of the elongated body to a distal joint that is adjacent to a distal tip. Each leg may have a center that is substantially parallel to the elongated body so that there is sufficient contact between the airway walls and the parallel portion of the leg. The center that is substantially parallel is usually referred to as the active region of the leg. The
- The legs of this variation may be spaced around a circumference of the elongated body to form a basket. The legs of this variation may have a circular cross section or a rectangular cross section, or other non-axisymmetric cross sections. The cross sections may be chosen to allow ready deployment from a first state to a second expanded state, while resisting out-of-plane bending which may distort the spacing of the legs or the contact of electrodes with the airway surface. One variation of the invention includes a basket in which the distance between the proximal and distal joint is less than 35 mm when the basket is not expanded. Another variation of this invention includes a basket that comprises four or five legs. In this case, the legs may be placed evenly around a circumference of the elongated body. In this case the legs may be found at intervals of 90 or 72 degrees. Other variations of the invention include devices having less than four legs or more than five legs. Another variation of this inventive device includes placing a temperature detecting element on one or on more legs. In this variation, the temperature of one leg may be monitored or the temperature of several legs may be independently monitored to control the energy delivery. In a further variation, multiple temperature sensing elements may be combined with independent control of energy to each leg. Both of these variations may also apply to a variation of the device having pre-shaped tines. The legs may be soldered or made to adhere using adhesives to the elongated body at the proximal and distal ends. Another variation of the invention includes a multi-lumen elongated body into which a portion of each leg is inserted. It is also contemplated that an elongated member may be reinforced via a reinforcing member. Such a reinforcing member may include a coiled or braided wire, polymeric insert, or any other similar reinforcing member.
- The energy transfer element of the invention may include an element that directly heats tissue by delivering current such as an RF based electrode. The RF electrode may be either bipolar or monopolar or a heated element that conductively heats tissue. In variations of the invention using RF energy, the frequency of the RF may be selected to be in the 400 kHz range or any other standard medical range used in electro-surgical applications.
- When the electrode directly heats the tissue, the heated element may use AC or DC current to resistively heat the element. RF energy may also be used to resistively heat the element. An indirect method of heating includes a resistively heated element that conducts heat to the expandable portion or directly to the airway. The invention may also include a combination of the types of electrodes mentioned above.
- In the variation of the invention in which the expandable portion comprises a basket, each of the energy transfer elements may be a RF electrode that is attached to each leg. The electrode may be fastened by a heat shrink fastener. In such a case, a temperature detecting element may be placed on the leg and underneath the fastener. A resistance heating element may be coiled around a portion of the leg. In this case, a temperature detecting element may be placed underneath the coil. Other examples of the energy transfer element include a polymeric heating element, an electrically conductive paint, or a printed flex circuit which are on a portion of the leg. Another variation employs the basket leg itself as either a RF electrode or a heated element. In such cases, the temperature sensing element may be attached directly to a basket leg by soldering, welding, adhesive bonding, or other means.
- Another variation of the invention includes a sheath slidably coupled to and exterior to the expandable portion. The expandable portion may be resilient and self-expand into the second state when no longer confined by the sheath. For example, the sheath may be withdrawn in a proximal direction or the expandable portion may be advanced out of the sheath.
- Yet another variation of the invention includes a deployment member comprising a handle adjacent to a proximal end of the elongated body. The elongated body may be slidably attached to the handle. The deployment member may also comprise a wire that extends from the handle through the lumen of the elongated body and is fixedly attached to the distal tip. This wire may also provide a current to the energy transfer members. The elongated body, the wire, and the distal tip may be slidably moveable in a distal and proximal direction. This variation of the deployment member may also include a stop configured to prevent distal movement of the wire beyond a deployment point. In this variation, beyond the deployment point, movement of the elongated body against the non-moving distal tip causes the expansion member to expand from a first state into a second expanded state.
- Another variation of the invention includes a deployment member comprising a sheath that covers the elongated member and expandable portion and a handle at a proximal end of the sheath. The sheath may be slidably attached to the handle while the elongated member is rigidly attached to the handle. A wire may extend from said handle to a distal tip through a lumen of the elongated member. The variation may include a first control member attached to the sheath and slidably attached to the handle where proximal movement of the first control member causes the sheath to retract on the elongated member and uncover the expandable portion. This variation may also include a second control member which is attached to the wire where proximal movement of the second control member causes the distal tip and the expandable portion to retract against the non-moving elongated member and causes the expandable portion to radially expand into a second state.
- Another variation of the invention includes a deployment member having force compensation or deflection limiting stops to prevent over-expansion of the expandable member when deployed within the body.
- A variation of the invention includes placing a sheath exterior to the elongated body and expandable portion such that the expandable portion is placed within the sheath in a first unexpanded state. When the expandable portion is no longer restrained by the sheath, the expandable portion expands into its second state. The invention may also include a control member moveably secured to the handle where the member is configured to advance the elongated body and the wire in the distal and proximal directions. Another variation of the invention includes a detent means for maintaining the elongated body distally of the deployment point. The control member may also be configured to frictionally maintain the elongated body distally of the deployment point. In these cases, the expandable portion will be in the second expanded state. Other variations of the inventive device may include use of levers, control wheels, or screw mechanisms in place of a control member.
- Another variation of the inventive device includes a distal tip that may be configured to prevent gouging of the airway tissue. The distal tip may have a redundant joint to prevent separation of the tip from the apparatus. The distal tip may also be sized to fit within a bronchoscope.
- Another variation of the invention includes a central wire extending from the distal tip to the proximal portion of the device. The wire may be configured to provide a current to the energy transfer elements. A temperature detecting element may also be attached to the wire.
- The inventive device may also be radiopaque or may have radiopaque elements.
- Another variation of the invention includes providing a steering member in the device to deflect the distal tip of the apparatus in a desired direction.
- Another variation of the invention includes placing a vision system on the apparatus. The vision system may include a fiber-optic cable or a CCD chip.
- Another variation of the invention includes providing a power supply configured to deliver energy through the energy transfer elements to the airway walls. The power supply may be configured to include a high temperature shut off or one which shuts down if a minimum temperature is not detected within a predetermined time or if a minimum temperature slope is not detected during a predetermined time.
- The invention further includes a kit comprising an energy transfer apparatus for facilitating energy transfer into a mass of airway tissue and a generator configured to delivery energy to the energy transfer apparatus. The kit may further include a bronchoscope.
- The invention further includes an energy transfer apparatus for facilitating energy transfer into a mass of airway tissue within a lung, the energy transfer apparatus having been rendered sterile for the purposes of prevention of infection of the lung.
- The invention further includes a modified lung configured to have an artificially altered airway within the lung, the airway being artificially altered by transfer of energy to the airway such that the airway has a reduced ability to constrict, an increased airway diameter, a increase in resistance to plugging, and a decrease in resistance to airflow.
- The present invention may be used for a treatment of asthma or other constriction or spasm of a bodily conduit by application of energy. The treatment reduces the ability or propensity of the airway to contract, reduces plugging of the airway, increases the inner airway diameter, and/or reduces resistance to flow through the airway.
- The invention will now be described in greater detail with reference to the various embodiments illustrated in the accompanying drawings:
-
FIG. 1 is a cross sectional view of a medium sized bronchus in a healthy patient. -
FIG. 2 is a cross sectional view of a bronchiole in a healthy patient. -
FIG. 3 is a cross sectional view of the bronchus ofFIG. 1 showing the remodeling and constriction occurring in an asthma patient. -
FIG. 4 is an illustration of the lungs being treated with a device according to the present invention. -
FIG. 5A is a partial side view of a variation of the inventive device having a plurality of wire shaped electrodes. -
FIG. 5B is a cross sectional side view of another variation of a device having a plurality of wire shaped electrodes with a deployment wire attached to a distal tip of the device. -
FIG. 5C shows a partial view of a variation of an elongated member of inventive device having a plurality of lumens for nesting the legs of the basket. -
FIGS. 5D-5I illustrate a variation of the invention and a deployment member for deploying the device. -
FIGS. 5J-5L illustrate examples of energy transfer elements of the device. -
FIG. 5M shows a partial view of a thermocouple attached to a basket leg. -
FIGS. 6A-6D illustrates distal joints of the invention. -
FIG. 6E illustrates a proximal joint of the invention. -
FIGS. 7A-7D illustrates a series and parallel wiring of legs of the basket. -
FIGS. 8A-8C illustrate examples of variable thicknesses of legs of the basket. -
FIGS. 9A-9D illustrate examples of a basket formed from a single sheet or piece of material. -
FIG. 10 is a side cross sectional view of a variation of the inventive device having a balloon with electrodes positioned exterior to the balloon. -
FIG. 11 is a partial side view of a variation of the inventive device having a balloon with heat generating elements positioned within the balloon for indirect heating of the tissue. -
FIG. 12 is cross sectional view of the inventive device with electrodes and pre-shaped tines as the expandable member. -
FIG. 13 is a cross sectional view of a variation of the inventive device with energy transfer elements positioned on expandable balloons. -
FIG. 14 is an illustration of a variation of the inventive device with electrodes positioned in grooves. -
FIG. 15 is an illustration of a variation of the inventive device with electrodes and a biasing element. -
FIG. 16 is an illustration of another variation of the inventive device having electrodes and a biasing element. -
FIG. 17 is a partial side view of a variation of the inventive device having electrodes exposed by cut away sections of an elongated member. -
FIG. 18 is a partial side view of the inventive device with electrodes positioned on a loop shaped member. -
FIG. 19 is a cross sectional view of a variation of the inventive device having a looped shaped electrode in an unexpanded position. -
FIG. 20 is a cross sectional view of the variation ofFIG. 19 with the looped shape electrode in an expanded position. - The inventive airway energy treatment may be used to reduce the ability of the airways to narrow or to reduce in diameter due to airway smooth muscle contraction. This treatment to reduce the ability of the smooth muscle to contract lessens the severity of an asthma attack. The reduction in the ability of smooth muscle to contract may be achieved by treating the smooth muscle itself or by treating other tissues which in turn influence smooth muscle contraction or the response of the airway to smooth muscle contraction. Treatment may also reduce airway responsiveness or the tendency of the airway to narrow or to constrict in response to a stimulus.
- The amount of smooth muscle surrounding the airway can be reduced by exposing the smooth muscle to energy which either kills the muscle cells or prevents these cells from replicating. The reduction in smooth muscle reduces the ability of the smooth muscle to contract and to narrow the airway during a spasm. The reduction in smooth muscle and surrounding tissue has the added potential benefit of increasing the caliber or diameter of the airways, reducing the resistance to airflow through the airways. In addition to use in debulking smooth muscle tissue to open up the airways, the device of the present invention may also be used for eliminating the smooth muscle altogether by thermally damaging or destroying it. The elimination of the smooth muscle prevents the hyper-reactive airways of an asthma patient from contracting or spasming, reducing or eliminating this asthma symptom.
- The ability of the airway to contract can also be altered by treatment of the smooth muscle in particular patterns. The smooth muscle is arranged around the airways in a generally helical pattern with pitch angles ranging from about −30 to about +30 degrees. Thus, the treatment of the smooth muscle by energy which is selectively delivered in an appropriate pattern interrupts or cuts through the helical pattern at a proper pitch and prevents the airway from constricting. This procedure of patterned application of energy eliminates contraction of the airways without completely eradicating smooth muscle and other airway tissue. A pattern for treatment may be chosen from a variety of patterns including longitudinal or axial stripes, circumferential bands, helical stripes, and the like as well as spot patterns having rectangular, elliptical, circular or other shapes. The size, number, and spacing of the treatment bands, stripes, or spots are chosen to provide a desired clinical effect of reduced airway responsiveness while limiting insult to the airway to a clinically acceptable level.
- The patterned treatment of the tissues surrounding the airways with energy provides various advantages. The careful selection of the portion of the airway to be treated allows desired results to be achieved while reducing the total healing load. Patterned treatment can also achieve desired results with decreased morbidity, preservation of epithelium, and preservation of a continuous or near continuous ciliated inner surface of the airway for mucociliary clearance. The pattern of treatment may also be chosen to achieve desired results while limiting total treatment area and/or the number of airways treated, thereby improving speed and ease of treatment.
- Application of energy to the tissue surrounding the airways also may be used to cause the DNA of the cells to become cross linked. The treated cells with cross linked DNA are incapable of replicating. Accordingly, over time, as the smooth muscle cells die, the total thickness of smooth muscle decreases because of the inability of the cells to replicate. The programmed cell death causing a reduction in the volume of tissue is called apoptosis. This treatment does not cause an immediate effect but causes shrinking of the smooth muscle and opening of the airway over time and substantially prevents re-growth. The application of energy to the walls of the airway may also be used to cause a cross linking of the DNA of the mucus gland cells thereby preventing them from replicating and reducing excess mucus plugging or production over time.
- The ability of the airways to contract may also be reduced by altering mechanical properties of the airway wall, such as by increasing stiffness of the wall or by increasing parenchymal tethering of the airway wall. Both of these methods increase the strength of the airway wall and opposes contraction and narrowing of the airway.
- There are several ways to increase the stiffness of the airway wall. One way to increase stiffness is to induce fibrosis or wound healing response by causing trauma to the airway wall. The trauma can be caused by delivery of therapeutic energy to the tissue in the airway wall or by mechanical insult to the tissue. The energy is preferably delivered in such a way that it minimizes or limits the intra-luminal thickening that can occur.
- Another way to increase the effective stiffness of the airway wall is by altering the submucosal folding of the airway upon narrowing. The submucosal layer is directly beneath the epithelium and its basement membrane and inside the airway smooth muscle. As an airway narrows, its perimeter remains relatively constant, with the mucosal layer folding upon itself. As the airway narrows further, the mucosal folds mechanically interfere with each other, effectively stiffening the airway. In asthmatic patients, the number of folds is fewer and the size of the folds is larger, and thus, the airway is free to narrow with less mechanical interference of mucosal folds than in a healthy patient. Thus, asthmatic patients have a decrease in airway stiffness and the airways have less resistance to narrowing.
- The mucosal folding in asthmatic patients can be improved by treatment of the airway in a manner which encourages folding. Preferably, a treatment will increase the number of folds and/or decrease the size of the folds in the mucosal layer. For example, treatment of the airway wall in a pattern such as longitudinal stripes can encourage greater number of smaller mucosal folds and increase airway stiffness.
- The mucosal folding can also be increased by encouraging a greater number of smaller folds by reducing the thickness of the submucosal layer. The decreased thickness of the submucosal layer may be achieved by application of energy which either reduces the number of cells in the submucosal layer or which prevents replication of the cells in the submucosal layer. A thinner submucosal layer will have an increased tendency to fold and increased mechanical stiffening caused by the folds.
- Another way to reduce the ability of the airways to contract is to improve parenchymal tethering. The parenchyma surrounds airways and includes the alveolus and tissue connected to and surrounding the outer portion of the airway wall. The parenchyma includes the alveolus and tissue connected to and surrounding the cartilage that supports the larger airways. In a healthy patient, the parenchyma provides a tissue network which connects to and helps to support the airway. Edema or accumulation of fluid in lung tissue in asthmatic patients is believed to decouple the airway from the parenchyma reducing the restraining force of the parenchyma which opposes airway constriction. Application of therapeutic energy can be used to treat the parenchyma to reduce edema and/or improve parenchymal tethering.
- In addition, the applied energy may be used to improve connection between the airway smooth muscle and submucosal layer to the surrounding cartilage, and to encourage wound healing, collagen deposition, and/or fibrosis in the tissue surrounding the airway to help support the airway and prevent airway contraction.
- Airway diameter in asthmatic patients is reduced due to hypertrophy of the smooth muscle, chronic inflammation of the airway tissues, and general thickening of all parts of the airway wall. The overall airway diameter can be increased by a variety of techniques to improve the passage of air through the airways. Application of energy to the airway smooth muscle of an asthmatic patient can be used to debulk or reduce the volume of smooth muscle. This reduced volume of smooth muscle increases the airway diameter for improved air exchange.
- The airway diameter can also be increased by reducing inflammation and edema of the tissue surrounding the airway. Inflammation and edema (accumulation of fluid) of the airway occur in an asthmatic patient due to irritation. The inflammation and edema can be reduced by application of energy to stimulate wound healing and regenerate normal tissue. Healing of the epithelium or sections of the epithelium experiencing ongoing denudation and renewal allows regeneration of healthy epithelium with less associated airway inflammation. The less inflamed airway has an increased airway diameter both at a resting state and in constriction. The wound healing can also deposit collagen which improves parenchymal tethering.
- Inflammatory mediators released by tissue in the airway wall may serve as a stimulus for airway smooth muscle contraction. Smooth muscle contraction, inflammation, and edema can be reduced by a therapy which reduces the production and release of inflammatory mediators. Examples of inflammatory mediators are cytokines, chemokines, and histamine. The tissues which produce and release inflammatory mediators include airway smooth muscle, epithelium, and mast cells. Treatment of these structures with energy can reduce the ability of the airway structures to produce or release inflammatory mediators. The reduction in released inflammatory mediators will reduce chronic inflammation, thereby increasing the airway inner diameter, and may also reduce hyper-responsiveness of the airway smooth muscle.
- A further process for increasing the airway diameter is by denervation. A resting tone of smooth muscle is nerve regulated by release of catecholamines. Thus, by damaging or eliminating nerve tissue in the airways the resting tone of the smooth muscle will be reduced, and the airway diameter will be increased.
- Excess mucus production and mucus plugging are common problems during both acute asthma exacerbation and in chronic asthma management. Excess mucus in the airways increases the resistance to airflow through the airways by physically blocking all or part of the airway. Excess mucus may also contribute to increased numbers of leukocytes found in airways of asthmatic patients by trapping leukocytes. Thus, excess mucus can increase chronic inflammation of the airways.
- One type of asthma therapy involves treatment of the airways with energy to target and reduce the amount mucus producing cells and glands and to reduce the effectiveness of the remaining mucus producing cells and glands. The treatment can eliminate all or a portion of the mucus producing cells and glands, can prevent the cells from replicating or can inhibit their ability to secrete mucus. This treatment will have both chronic benefits in increasing airflow through the airways and will lessen the severity of acute exacerbations.
- Illustrated below are different treatment devices for transferring energy into the airways. Described below are just some of the examples of the type of treatment devices which may be used to treat airway tissue according to the present invention. It should be recognized that each of the treatment devices described below can be modified to deliver or to remove energy in different patterns depending on the treatment to be performed. The treatment devices may be actuated continuously for a predetermined period while stationary, may be pulsed, may be actuated multiple times as they are moved along an airway, may be operated continuously while moving the device in an airway to achieve a “painting” of the airway, or may be actuated in a combination of any of these techniques. The particular energy application pattern desired can be achieved by configuring the treatment device itself or by moving the treatment device to different desired treatment locations in the airway.
- The treatment of an airway with the treatment device may involve placing a visualization system such as an endoscope or bronchoscope into the airways. The treatment device is then inserted through or next to the bronchoscope or endoscope while visualizing the airways. Alternatively, the visualization system may be built directly into the treatment device using fiber optic imaging and lenses or a CCD and lens arranged at the distal portion of the treatment device. The treatment device may also be positioned using radiographic visualization such as fluoroscopy or other external visualization means. The treatment device which has been positioned with a distal end within an airway to be treated is energized so that energy is applied to the tissue of the airway walls in a desired pattern and intensity. The distal end of the treatment device may be moved through the airway in a uniform painting like motion to expose the entire length of an airway to be treated to the energy. The treatment device may be passed axially along the airway one or more times to achieve adequate treatment. The “painting-like” motion used to exposed the entire length of an airway to the energy may be performed by moving the entire treatment device from the proximal end either manually or by motor. Alternatively, segments, stripes, rings or other treatment patterns may be used.
- According to one variation of the invention, the energy is transferred to or from an airway wall in the opening region of the airway, preferably within a length of approximately two times the airway diameter or less, and to wall regions of airways distal to bifurcations and side branches, preferably within a distance of approximately twice the airway diameter or less. The invention may also be used to treat long segments of un-bifurcated airway.
- There are several ways to decrease the resistance to airflow though the airways which occurs in asthma patients both at rest and during an asthma attack. One such treatment alters the structure of the airway, such as by reducing the amount of airway tissue. For example, the addition of energy to the airway tissue may cause the DNA of the muscle cells to become cross linked. The smooth muscle cells with cross linked DNA cannot replicate. Thus, over time, as smooth muscle cells die, the total thickness of the muscle decreases because of the inability of the cells to replicate. Another treatment alters the function of the airway, such as by reducing smooth muscle contraction, mucus gland secretions, or disrupting the inflammatory response. These treatments can be performed by applying energy of different types and in different patterns to achieve the desired results. In such cases, stiffness of the airway is increased as the energy induces a fibrosis or wound healing response that causes trauma to the airway wall.
-
FIGS. 1 and 2 illustrate cross sections of two different airways in a healthy patient. The airway ofFIG. 1 is a medium sized bronchus having an airway diameter D1 of about 3 mm.FIG. 2 shows a section through a bronchiole having an airway diameter D2 of about 1.5 mm. Each airway includes a folded inner surface orepithelium 10 surrounded bystroma 12 andsmooth muscle tissue 14. The larger airways including the bronchus shown inFIG. 1 also havemucous glands 16 andcartilage 18 surrounding thesmooth muscle tissue 14.Nerve fibers 20 andblood vessels 22 also surround the airway. -
FIG. 3 illustrates the bronchus ofFIG. 1 in which thesmooth muscle 14 has hypertrophied and increased in thickness causing the airway diameter to be reduced from the diameter D1 to a diameter D3. -
FIG. 4 is a schematic side view of the lungs being treated with anenergy transferring apparatus 30 according to the present invention. Thedevice 30 is an elongated member for facilitating exchanging energy with a mass of airway tissue at atreatment site 34 within the lungs. Thedevice 30 must be of a size to access the bronchus or bronchioles of the human lung. The device may be sized to fit within bronchoscopes, preferably, with bronchoscopes having a working channel of 2 mm or less. Also, the device should be of sufficient stiffness to fit and operate through the seal covering the working channel a bronchoscope. - The energy may be delivered by the
treatment device 30 in a variety of treatment patterns to achieve a desired response. Examples of patterns are discussed in further detail below. The energy which is delivered by thetreatment device 30 may be any of a variety of types of energy including, but not limited to, radiant, laser, radio frequency, microwave, heat energy, or mechanical energy (such as in the form of cutting or mechanical dilation). - Also, the device may, but is not necessarily, configured to deliver energy in non-intersecting strip patterns which are parallel with a central axis of an airway. For example, other variations of the device may be configured to deliver energy in a torsional pattern, or in a circumferential pattern around a wall of the airway. Such configurations which may be determined to deliver energy to the airway tissue that maximize the ability of the airway to permit airflow are considered to be within the scope of this invention.
- The inventive devices include tissue contacting electrodes configured to be placed within the airway. These devices can be used for delivering radio frequency in either a monopolar or a bipolar manner or for delivering other energy to the tissue, such as conducted heat energy from resistively heated elements. As shown in
FIG. 4 , for monopolar energy delivery, one or more electrodes of the treatment device are connected to a single pole of theenergy source 32 and an optionalexternal electrode 44 is connected to an opposite pole of the energy source. For bipolar energy delivery, multiple electrodes are connected to opposite poles of theenergy source 32 and theexternal electrode 44 is omitted. Naturally, theexternal electrode 44 depicted inFIG. 4 , is not required in the case of bipolar energy delivery. The number and arrangement of the electrodes may vary depending on the pattern of energy delivery desired. The treatment devices ofFIGS. 5A-10 , and 12-20 are used to deliver radiant or heat energy to the airway. The treatment device ofFIG. 11 may also be used to deliver indirect radio frequency, microwave energy, or conductive heat energy to the tissue. In cases of heat energy generated by resistive heating, the current may be AC or DC current or in the case of AC, the current may be delivered in the RF range. The use of RF provides an added safety feature of minimizing the possibility of harm to the patient caused by escaped current. The device may also use a combination of any of the energy transferring element configurations described herein. - The following illustrations are examples of the invention described herein. It is contemplated that combinations of aspects of specific embodiments or combinations of the specific embodiments themselves are within the scope of this disclosure.
- The
treatment device 302 ofFIG. 5A includes anelongated member 102 for delivering anexpandable member 104 to a treatment site. Theexpandable member 104 may have a plurality of energy transfer elements (not illustrated) which are placed on a plurality ofbasket legs 106 to transfer energy at the treatment site. In this variation, the expandable member comprises abasket 104 which is defined by a number ofbasket legs 106. Thebasket legs 106 are formed from a plurality of elements which are soldered or otherwise connected together at two connection areas, a proximal joint 108 and adistal joint 110. - A desirable length of the
basket 104, or the expandable portion of any variation of the invention, depends upon numerous factors. One consideration in determining a desired length of the expandable member, e.g., the distance between the joints of the basket, of the inventive device is related to the dimension of the target area or treatment region. For instance, some other factors include considerations of minimizing the amount of the expandable portion which is distal to the treatment region for optimized access, minimizing the amount of the expandable portion that is proximal to the treatment region for visualization and access concerns, and setting a desirable length of the expandable portion that will contact a sufficient portion of the treatment region during each application of the device. A compromise of such factors along with other considerations provides a desirable length for the expandable portion of the device. Preferably, the distance between the distal and proximal joints of the basket is less than 35 mm when the basket is in a first unexpanded state. - The
legs 106 may be selected from a material that allows the basket to expand without plastic deformation. For example, the legs may comprise a stainless steel, or a shape memory/superelastic alloy such as a nitinol material. Thebasket legs 106 may have a rectangular cross section in those variations where thelegs 106 are formed from ribbons, or thelegs 106 may have a circular cross section in those variations where the legs are formed from wires. As discussed below, thelegs 106 may also have other cross section as desired. It is also contemplated that thelegs 106 need not all have similar cross sections. For instance, the cross section of each of thelegs 106 in abasket 104 may be individually chosen to optimize such factors as the resilience of thebasket 104, or to optimize energy transfer characteristics. The legs may also have a variable cross section along the length of the basket. - Illustrated are variations of the
inventive device 302 having abasket 104 comprising of fourlegs 106. It is preferred that thelegs 106 are spaced at equal intervals around the expandable member orbasket 104. For example, in variations of the invention having fourlegs 106, thelegs 106 are preferably, but not necessarily spaced at approximately 90 degree intervals around thebasket 104. In variations having fivelegs 106, thelegs 106 may be spaced at approximately 72 degree intervals. Other variations of the invention include devices having less than four legs or more than five legs. It is thought that the most effective number of legs is a compromise based on the size of the target airway, contact surface between theleg 106 and airway wall, and the maximum outer diameter of theelongated member 102. - The proximal 108 and/or distal 110 joints may also contain adhesive to bind the
legs 106. Thebasket legs 106 between the proximal 108 and distal joint 110 are formed into thebasket shape 104 so that arch shaped portions of thebasket legs 106 will contact the walls of an airway to facilitate energy transfer. Although the figures illustrate thebasket legs 106 as having a semi-circular or arc shape the device is not limited to such shapes. For example, thelegs 106 may have a more oblong shape or sharper bends to allow for a more parallel leg surface area that contacts the target tissue. Eachleg 106 may have a center that is substantially parallel to the elongated body so that there is sufficient contact between the airway walls and the parallel portion of theleg 106. The center that is substantially parallel is usually referred to as the active region of theleg 106. - The length of the
basket 104 between the proximal and distal 110 joints may be less than 35 mm when thebasket 104 is in a first unexpanded state. Thelegs 106 may be coated with an insulating material (not shown) except at the tissue contact points. Alternatively, thelegs 106 of thebasket 104 may be exposed while the proximal 108 and distal joint 110 are insulated. In this variation, thebasket 104 is formed of a resilient material which allows the distal end of theinventive device 302 to be confined by a sheath (not shown) for delivery of thedevice 302 to the treatment site and allows thebasket 104 to return to its original basket shape upon deployment. In other words, a variation of the invention is that the basket self-expands from a first state to a second expanded state upon the removal of any constraining or restrictive member such as a sheath (not shown). Theinventive device 302 is preferably configured such that thebasket legs 106 have sufficient resilience to come into contact with the airway walls for treatment. -
FIG. 5A further illustrates a variation of theinventive device 302 in which a distal end of thedevice 302 is provided with adistal tip 112 that can have a radius to facilitate insertion of thedevice 302 into the lungs and also to minimize the possibility of causing trauma to surrounding tissue. Thetip 112 is preferably sized to prevent the gouging of airway by the sheath. The design of the distal tip is selected to be atraumatic. The size of the tip may be selected to be large enough to prevent the sheath from gouging airways yet small enough to pass in and out of a bronchoscope. -
FIG. 5B illustrates a variation of theinventive device 302 havingbasket legs 108 connected to adistal end 114 of theelongated member 102 and forming abasket 104. In this variation, a proximal joint is found at thedistal end 114 of theelongated member 102. Thebasket 104 is expanded radially, to its second state, during use to ensure contact between the energy transfer elements (not shown) and the airway walls (not shown) by, for example, pulling on acenter pull wire 116 which is connected to adistal tip 118 of theexpandable portion 104. Thecenter pull wire 116 may extend through a lumen of theelongated member 102 towards a proximal portion (not shown) of theelongated member 102. It is also contemplated that thecenter pull wire 116 may be configured to deliver current to the energy transfer elements found on theexpandable member 104. Theinventive device 302 may be delivered to a treatment site through adelivery sheath 120 and may be drawn along or moved axially along the airway to treat the airway in a pattern of longitudinal or helical stripes. - As noted above, the
basket 104 may be resilient or self-expanding (e.g., seeFIG. 5A ) to expand to a second expanded state or thebasket 104 may require an expanding force (e.g., seeFIG. 5B ). An example of this variation of theinventive device 304 is shown inFIG. 5B . In this variation, thebasket 104 may be resilient and thesheath 120 may comprise the deployment member. In this variation, when theelongate body 102 andbasket 104 are withdrawn into thesheath 120, thebasket 104 contracts within thesheath 120 and assumes a first state. In one variation of the invention, upon advancing thebasket 104 andelongate body 102 out of thesheath 120, thebasket 104 may resiliently assume a second expanded state. In another variation of the invention, thebasket 104 may assume a second expanded state with the aid of awire 116. This wire may also be configured to deliver power to theenergy exchange elements 106. -
FIG. 5C illustrates another variation of the inventive device where anelongated member 102 of is configured to have a plurality of lumens 140 so that each of thebasket legs 106 are isolated within the lumens 140 of theelongated member 102 until thelegs 106 exit theelongated member 102 and connect at a proximal joint 108. The invention may havebasket legs 106 selected with a sufficient length such that the ends of each of thelegs 106 extend substantially into the lumens 140. As a result of being inserted deeply within the lumen, the ends of thelegs 106 would require significant travel before they exited the lumen 140. This feature provides added safety as it minimizes the risk of thebasket legs 106 dislodging from theelongate member 102. - In another variation of the invention, the
elongated member 102 may comprise concentric tubes (not shown) rather than multi-lumen tubes where basket legs are inserted in the annulus between the tubes. It is also contemplated that an elongated member may be reinforced with the use of a reinforcing member. Such a reinforcing member may include a coiled wire or polymeric insert. -
FIG. 5D-5I illustrate variations of the inventive device that use an expanding force to expand the basket.FIG. 5D illustrates a deployment member of the device.FIG. 5E illustrates the device ofFIG. 5D when the elongated member is moved in a distal direction to a deployment point.FIG. 5F-5G illustrates theelongated member 102,sheath 120,expandable member 104,distal tip 118, andwire 122 extending through the device.FIG. 5F illustrates thebasket 104 in a first unexpanded state when theelongated member 102 andwire 122 are proximal of thedeployment point 130.FIG. 5G illustrates the expansion of thebasket 104 to a second expanded state as theelongated member 102 moves distally and thewire 122 is restrained at thedeployment point 130. - Turning now to
FIG. 5D , the deployment member may comprise ahandle 124 which is adjacent to a proximal portion of anelongated member 102. The handle may be designed to be operated by a single hand, either right or left. The handle may also have a control switch for operation of the device. Such a switch could control the power supply attached to the device as well. Also, the handle may be configured to determine the position of the device within a human body as the device is advanced to a target site. For example, marks on the handle or even a readout could provide information to the user as to the relative deployment state of the expandable member. Also, a sensor may be placed on thehandle 124, this sensor may be used to determine the position of the expandable member. Such a sensor could also be used to measure the size of the airway, such a measurement could be used as a control variable to determine the amount of energy that the device power supply must deliver. Thehandle 124 may control the expandable member using force compensation (e.g., a spring, etc.) or deflection limiting stops to control the expansion of the expandable member. Such force compensation or deflection stops provide a limit to the expansion member to avoid over-expansion of a particular airway. - Turning now to the
handle 124 ofFIG. 5D , anelongated member 102 may be slidably mounted to the handle. The variation of the invention depicted in these Figures may also, but does not necessarily, include asheath 120 exterior to theelongated body 102. Awire 122 extends from the handle through theelongated member 102 and may be attached to adistal tip 118 of the device. Thewire 122,elongated member 102, and distal tip (not shown) are slidably moveable in both a distal and proximal directions. The handle may also include astop 126 which prevents thewire 122 from moving distally beyond adeployment point 130. Thestop 126 may be connected to a spring (not shown) to limit the expansion of the expandable member upon reaching a pre-determined force. Thehandle 124 may include acontrol member 128 that is moveably attached to thehandle 124 for moving theelongated member 102 in a distal/proximal direction. Although thehandle 124 in the figures is depicted to have acontrol member 128 as illustrated, other variations of control members are also contemplated to be within the scope of this invention. For example, though not illustrated, ahandle 124 may include other configurations, such as lever, thumb-wheel, screw-mechanism, ratchet mechanism, etc., which are attached to thehandle 124 to provide control actuation for the expandable member. -
FIG. 5E illustrates a variation of the inventive device when theelongated member 102 andwire 122 are moved in a distal direction. In this illustrations, astop 126 prevents thewire 122 from moving distally of adeployment position 130. This illustration further illustrates a variation of the invention where thestop 126 is attached tosprings 127 which provide force compensation for the expandable member on the device. Although not shown, acontrol member 128 may have a stop which limits its travel along ahandle 124. Such a stop is an example of a deflection limiting mechanism which controls the movement of thecontrol member 128, thus controlling the extent of the expansion of the expandable member. -
FIG. 5F illustrates the invention when the expandable member orbasket 104 is in a first unexpanded state. As noted above, thewire 122 is attached to adistal tip 118 of the device and both are prevented from distal movement when thewire 122 is in thedeployment position 130. Therefore, as depicted inFIG. 5G , movement of theelongated member 102 in a distal direction against adistal tip 118, that is restrained by awire 122, causes abasket 104 to compress between the advancingelongated member 102 and the stationarydistal end 118. Thus, thebasket 104 is forced outward and radially expands into a second expanded state. As noted above, thewire 122 may also be used to transfer energy to or from the energy transfer elements found on thebasket 104. Also, it is contemplated that thewire 122 may be a wire, a ribbon, a tube, or of any other equivalent structure. Also contemplated, but not shown, is a detent means for maintaining the elongated member in a distal position to expand thebasket 104 against thedistal tip 118 without the need for continual applied force by a user of the device. Also contemplated is a ratchet member, or friction member to maintain thebasket 104 in the expanded state. -
FIG. 5H illustrates another variation of a deployment member. In this variation, asheath 120 may be slidably attached to ahandle 124. In this variation, theelongate member 102 is rigidly attached to thehandle 124. Thesheath 120 may be attached to afirst control member 129. Awire 122 extends through theelongate member 102 and is attached to the distal tip of the device (not shown). Thewire 122 may be attached to asecond control member 131. As indicated inFIG. 5I , proximal movement of thefirst control member 129 causes thesheath 120 to proximally retract over theelongate member 102 and uncover the expandable portion (not shown). Proximal movement of thesecond control member 131 causes thewire 122, distal joint, and expandable member to move against the non-movingelongate member 102 which causes the expandable member to expand into a second state. - Turning now to the energy transfer elements located on the expandable portion,
FIG. 5J-5L illustrate examples of energy transfer elements that may be located on the expandable portion of the device. In the variation of the invention where the expandable portion comprises a basket havingbasket legs 106, thebasket legs 106 may function as heat exchange elements. In other words, the device may be configured so that the leg is an electrode or the conductive heating element. In these variations, theleg 106 may be partially covered with an insulation only leaving an active region exposed for delivery of energy to the airways. Examples of such insulation include a heat shrink sleeve, a dielectric polymeric coating, or other material which may function as an insulator. -
FIG. 5J illustrates an example of abasket leg 106 with anenergy transferring element 132 coiled around theleg 106. In this example, the energy transferring element uses conductive heating and comprises aresistance heating element 132 coiled around theleg 106.FIG. 5K illustrates a variation of the invention having an RF electrode attached to thebasket leg 106. The RF electrode may be attached to thebasket leg 106 via the use of afastener 134. For example, the electrode may be attached via the use of aheat shrink fastener 134, (e.g., polymeric material such as PET or polyethylene tubing). -
FIG. 5L illustrates another variation of the invention where the energy transfer element is a printedcircuit 138 that is situated around theleg 106 and secured to the leg. Also contemplated, but not shown for use as energy transfer elements are a polymeric heating material, an electrically conductive paint, a resistance element sputtered onto the leg in a pattern or formed on a substrate by photofabrication. Also, the basket leg itself may be chosen of appropriate size and resistivity to alloy dual use as a basket and energy transfer element. Many nickel-chromium alloys have both high specific resistance and significant spring-like properties. In any variation of the invention the use of adhesives or other coatings may also be used to secure the energy transfer element to thebasket leg 106. Also, the energy transfer elements are not limited to what is illustrated in the drawings. It is also contemplated that other types of energy transferelements may be used such as radiant, laser, microwave, and heat energy. -
FIG. 6A illustrates a variation of adistal tip 210 having a redundant joint. Thedistal tip 208 has apolymeric cap 210 covering the distal ends of thebasket legs 106 andwire 212. Thelegs 106 are soldered 214 to the distal end of thewire 212. Also used to maintain the joint is an adhesive 216 substantially filling thepolymeric cap 210. Amulti-lumen piece 218 separates thelegs 106 andwire 212. A side view of themulti-lumen piece 218 is shown inFIG. 6B . A multi-lumen tubing may be used for themulti-lumen piece 218. The ends 220 of thepolymeric cap 210 may be heat formed or otherwise tapered down around thelegs 106. -
FIG. 6C illustrates another variation of adistal tip 222 having a redundant joint. Thedistal tip 222 has apolymeric cap 210 covering the distal ends of thebasket legs 106 andwire 212. Thelegs 106 are soldered 214 to the distal end of thewire 212. Also used to maintain the joint is an adhesive 216 substantially filling thepolymeric cap 210. A hypo-tube 224 covers thelegs 106 andwire 212. A side view of the hypo-tube 224 is shown inFIG. 6D . The distal end of the hypo-tube 224 may be flared to seat a ball located on a distal end of thewire 212 and thelegs 106. A proximal end of the hypo-tube 224 may be flared to provide greater interlock withends 220 of thepolymeric cap 210. As shown inFIG. 6C , the ends of thelegs 106 taper outwards from the hypo-tube 224 and form an area with a diameter larger than the end of thecap 226 which may be tapered down around thelegs 106 andwire 212. The ends 220 of thepolymeric cap 210 may be heat formed or otherwise tapered down. -
FIG. 6E shows another variation of the invention having a hoop orring 228 at a proximal joint of the device. Thehoop 228 may be soldered or welded to thelegs 106 and keeps thelegs 106 attached even if a joint fails between the legs and theelongate member 102. Also, thehoop 228 may electrically connect the legs, preventing disconnection ofsingle leg 106 having a temperature sensing element attached. - The invention also includes a temperature detecting element (not shown). Examples of temperature detecting elements include thermocouples, infrared sensors, thermistors, resistance temperature detectors (RTDs), or any other apparatus capable of detecting temperatures or changes in temperature. The temperature detecting element is preferably placed in proximity to the expandable member. In the variation illustrated in
FIG. 5C , a temperature sensor may be mounted along thepull wire 116. For the variations depicted inFIG. 5J-5L , a temperature sensor may be mounted between theenergy transfer elements leg 106. In one variation of the invention a temperature sensor is placed on asingle basket leg 106 to provide a signal to control energy transfer. It is also contemplated that a temperature sensor may be placed on more than onebasket leg 106, and/or on acentral wire 116 to provide control for multiple areas of energy transfer. The temperature sensor may be placed on the inside of thebasket leg 106 to protect the temperature sensor while still providing a position advantageous to determining the device temperature at the energy transfer element. -
FIG. 5M illustrates a variation of the invention having thermocouple leads 139 attached to aleg 106 of the device. The leads may be soldered, welded, or otherwise attached to theleg 106. This variation of the invention shows both leads 139 of thethermocouple 137 attached in electrical communication to aleg 106 atseparate joints 141. In this case, the temperature sensor is at the surface of the leg. This variation provides in case either joint becomes detached, the circuit will be open and thethermocouple 137 stops reading temperature. The device may also include both of the thermocouple leads as having the same joint. -
FIG. 7A-7D illustrate variations of the device in which impedance may be varied by wiring thebasket legs 106 in series or in parallel.FIG. 7A illustrates a series wiring diagram in which acurrent path 142 flows from a first leg to asecond leg 106, athird leg 106, and afourth leg 106 sequentially.FIG. 7B illustrates the series wiring diagram and shows asingle wire 143 connecting thelegs 106 in series. Thewire 143 may, for example, extend to a distal end of the leg and wrap over itself to the proximal end of theleg 106. A covering (not shown) may be placed over thewire 143 wrappedleg 106 at the proximal end of the device.FIG. 7C illustrates another variation of a series wiring diagram. In this example, awire 143 extends from the proximal end of aleg 106 to its distal end and then extends to the distal end of anadjacent leg 106 and extends back to the proximal end of theadjacent leg 106. -
FIG. 7D illustrates a parallel wiring diagram in which acurrent path 142 flows to eachleg 106. Series wiring has an added advantage in that all current will pass through each energy transfer element. By design, this configuration equalizes the heat dissipated at each leg through construction of legs with equal resistance. In addition, in the event of failure of any electrical connection, no energy is delivered. This provides an additional safety feature over parallel wiring. As mentioned elsewhere, the electrical current may be AC or DC. AC may be delivered in the RF range as a safety measure additional to electrical isolation. DC may be used to allow a portable device powered by a battery pack or provide an energy source within the device itself. -
FIG. 8A-8C illustrates variation of thelegs 106 of thebasket 104. As discussed above, the legs may, for example, comprise a stainless steel, or a shape memory/superelastic alloy such as a nitinol material. Thebasket legs 106 may have a rectangular cross section in those variations where thelegs 106 are formed from ribbons, or thelegs 106 may have a circular cross section in variations where thelegs 106 are formed from wires. Also, aleg 106 may be configured to have a non-axisymmetric cross-section. For example, the leg may have an oval or flat cross section as well. Thelegs 106 of abasket 104 need not all have similar cross sections. For instance, the cross section of each of thelegs 106 in abasket 104 may be individually chosen to optimize such factors as the resilience of thebasket 104, or to optimize energy transfer characteristics. An example of a cross section of abasket leg 106 is seen inFIG. 8A which illustrates a top view of abasket leg 106 that has a contouredshape 144. In this illustration, the energy exchange element is not shown in the figure for clarity. One of the purposes of such acontoured shape 144 is illustrated inFIG. 8B . When the basket (not shown) expands to its second state,leg 106 is configured to bend at or substantially near to points 146. A benefit of such a configuration is to allow a substantially parallel active surface as defined by thecontour shape 144.FIG. 8C illustrates another variation of aleg 106. In this variation, theleg 106 has a region of increaseddiameter 148 in the case of round wire, or increased width or thickness in the case of rectangular or other non-axisymmetric wire. Such aregion 106 could also be a flat wire with bumps or protrusions creating areas of increased width of the flat wire. Thisregion 148 may, for example, provide a stop that assists in locating insulation, heat shrink, or other external covering around theleg 106. Also contemplated is aleg 106 that consists of a composite construction. In this variation, theleg 106 may comprise of differing materials in predetermined regions to control the bending of theleg 106 as thebasket 104 expands, or the leg may be constructed of different materials to selectively control regions of deliver of energy on the leg. -
FIG. 9A-9D illustrates another variation of the inventive device in which the expandable member comprises basket from a single piece or sheet of material. Such a configuration could comprise an etched, machined, laser cut, or otherwise manufactured piece of metal.FIG. 9A illustrates a partial view of abasket 104 formed from a single piece of material. The thickness of the material is, for example 0.005 inches but may vary as desired. The illustration ofFIG. 9A shows thebasket 104 prior to being wrapped about the Z direction as indicated. As shown, thelegs 106 may be of varying length or they may be thesame length 106 or a combination thereof. Thebasket 104 may have adistal portion 164 orbasket head 164 which may be configured to facilitate construction of the device. For example, thebasket head 164 may be notched 166 to obtain a desired shape as the basket is wrapped about the Z direction.FIG. 9B illustrates a variation of thebasket head 165 being notched such thatsections 165 of the material may be bent from the plane of the material to formtabs 165.Tabs 165 may be used to form mechanical joints with another part, such as a distal tip cap.FIG. 9C illustrates another variation of abasket 104 made from a single piece of material. In this example, thelegs 106 of thebasket 104 are bent in a direction orthogonal to the plane of thebasket head 164. In this example, the distance between the ends of thelegs 106 may be, for example, about 2.75 inches.FIG. 9D illustrates a variation of the proximal ends of thelegs 106 of thebasket 104. In this example, the proximal ends of thelegs 106 may havefeatures 168 which promote the structural integrity of the proximal joint (not shown) of the device. In this variation, the ends of thelegs 106 have a saw-tooth design which improve the integrity of the proximal joint connecting thelegs 106 to the elongated member. The variation ofFIG. 9D also illustrates a proximal end of theleg 106 as having a radius, however, the end of theleg 106 may have other configurations as required. Also, thelegs 106 may have a width of, for example, 0.012 inches and a separation of, for example, 0.016 inches. However, these dimensions may vary as needed. -
FIG. 10 illustrates another variation of theinventive device 306 in which the expandable member comprises aballoon member 150. This variation of thedevice 306 includeselectrodes 154 positioned on an exterior surface of theballoon member 150. Theelectrodes 154 may be connected to an energy source (not shown) byleads 156 extending through the balloon and through the lumen of anelongated member 102. Theballoon member 150 may be filled with a fluid 152 such as saline or air to bring theelectrodes 154 into contact with theairway wall 10. As noted above, the electrodes may also be resistance heating elements, RF electrodes, or another suitable element for conducting energy transfer with the airway. Also, a single electrode may continuously surround a circumference of aballoon 150, or a plurality of electrodes may be spaced at certain intervals to substantially surround the circumference of aballoon 150. -
FIG. 11 illustrates another variation of theinventive device 308 in which the expandable member comprises aballoon member 150 in which afluid 152 within theballoon member 150 is heated by aheat generating element 158. Theheat generating elements 158 are illustrated in the shape of coils surrounding the shaft of theelongated member 102, however other types of heat generating elements (not shown) shapes may also be used. Theheat generating elements 154 may be used as resistance heaters by application of an electric current to the heat generating elements. Alternatively, radio frequency or microwave energy may be applied to theheat generating elements 158 to heat fluid 152 within theballoon member 150. The fluid may be configured to optimize conductive heat transfer from theelectrodes 158 to the exterior of theballoon member 150. The heat then passes from an exterior of theballoon 150 to theairway wall 10. Radio frequency or microwave energy may also be applied indirectly to the airway wall through the fluid and the balloon. In addition, hot fluid may be transmitted to theballoon member 150 from an external heating device for conductive heating of the airway tissue. - Another variation of the
inventive device 310 is illustrated inFIG. 12 includes a plurality ofenergy transfer elements 162 positioned onpre-shaped tines 160. Thepre-shaped tines 160 may be outwardly biased such that they expand from a first shape insidesheath 120 into a second expanded shape once advanced out ofsheath 120. Thetines 160 may also be configured so that they retract into a first state once withdrawn into asheath 120. Thepre-shaped tines 160 may be connected to anelongate member 102 which is positioned within asheath 120. Thepre-shaped tines 160 and theenergy transfer elements 162 may be delivered through adelivery sheath 120 to a treatment site within the airways. When thepre-shaped tines 160 exit a distal end of thesheath 120, thepre-shaped tines 160 may bend outward until theenergy transfer elements 162 come into contact with the airway walls for transfer of energy with the airway walls. -
FIG. 13 illustrates a variation of theinventive device 314 in which aelongated member 102 is provided with a plurality ofenergy transfer elements 170 positioned on at least oneinflatable balloon 172. Theenergy transfer elements 170 may be RF electrodes or resistance heating elements. Theballoons 172 are inflated through theelongated member 102 to cause theenergy transfer elements 170 to come into contact with theairway walls 10. Theenergy transfer elements 170 are preferably connected to the energy source (not shown) by conductive wires (not shown) which extend from theenergy transfer elements 170 through or along theballoons 172 and through theelongated member 102 to the energy source. In the variation where theenergy transfer elements 170 are RF electrodes, theelectrodes 170 may be used in a bipolar mode without an external electrode. Alternatively, theinventive device 314 may be operated in a monopolar mode with an external electrode (not shown, seeFIG. 4 ). Another variation of the invention includes using resistance heating elements as theenergy transfer elements 170. Theenergy transfer elements 170 may be a single continuous circular element or there may be a plurality ofelements 170 spaced around theballoons 172. - An alternative of the
inventive device 316 ofFIG. 14 includes anelongated member 102 having one ormore grooves 174 in an exterior surface. Positioned within thegrooves 174 areelectrodes 176 for delivery of energy to the airway walls. Although thegrooves 174 have been illustrated in a longitudinal pattern, the grooves may be easily configured in any desired pattern. Preferably, theinventive device 316 ofFIG. 14 includes a biasing member (not shown) for biasing theelongated member 102 against an airway wall such that theelectrodes 176 contact airway tissue. The biasing member (not shown) may be a spring element, an inflatable balloon element, or other biasing member. Alternatively, the biasing function may be performed by providing a preformed curve in theelongated member 102 which causes the device to curve into contact with the airway wall when extended from a delivery sheath (not shown). -
FIG. 15 illustrates a variation of theinventive device 318 having one ormore electrodes 178 connected to a distal end of anelongated tube 102. Theelectrodes 178 are supported between the distal end of theelongated tube 102 and adistal tip 180. A connectingshaft 182 supports thetip 180. Also connected between the distal end of theelongated member 102 and thedistal tip 180 is aspring element 184 for biasing theelectrodes 178 against a wall of the airway. Thespring element 184 may have one end which slides in a track or groove in theelongated member 102 such that thespring 184 can flex to a variety of different positions depending on an internal diameter of the airway to be treated. -
FIG. 16 illustrates an alternative of theinventive device 320 in which the one ormore electrodes 186 are positioned on abody 188 secured to an end of anelongated member 102. In theFIG. 16 variation, thebody 188 is illustrated as egg shaped, however, other body shapes may also be used. Theelectrodes 186 extend throughholes 190 in thebody 188 and along the body surface. A biasing member such as aspring element 184 is preferably provided on thebody 188 for biasing the body with theelectrodes 186 against the airway walls.Leads 192 are connected to theelectrodes 186 and extend through theelongated member 102 to the energy source not shown. -
FIGS. 17 and 18 illustrate embodiments of theinvention electrodes 194 in the form of wires are positioned in one ormore lumens 196 of anelongated member 102.Openings 198 are formed in side walls of theelongated member 102 to expose theelectrodes 194 to the surrounding tissue. As shown inFIG. 17 , theinventive device 322 may havemultiple lumens 196 withelectrodes 194 provided in each of thelumens 196. The side wall of theinventive device 322 is cut away to expose one or more of theelectrodes 194 through aside wall opening 198. InFIG. 17 , theopening 198 exposes twoelectrodes 194 positioned in adjacent lumens. Theinventive device 322 may be provided with a biasing member as discussed above to bring the electrodes 195 of the device into contact with the airway wall. - Another variation of the
inventive device 324 as shown inFIG. 18 includes anelongated member 102 which has an expandable loop shapedmember 202 to allow theelectrodes 194 to be exposed on opposite sides of thedevice 324 which contacts opposite sides of the airway. The resilience of the loop shapedmember 202 causes theelectrodes 194 to come into contact with the airway walls. -
FIGS. 19 and 20 illustrate a further variation of theinventive device 326 having anexpandable member 204 in a first non-expanded state and in a second expanded state.FIG. 19 illustrates the device as having one or more loop shapedelectrodes 204 connected to anelongated member 102. In the unexpanded position shown inFIG. 19 , the loop of theelectrode 204 lies along the sides of acentral core 206. A distal tip of theloop electrode 204 is secured to thecore 206 and to adistal tip 208. Thecore 206 may be slidable in a lumen of theelongated member 102. Once theinventive device 326 has been positioned with the distal end in the airway to be treated, theelectrode 204 is expanded by pulling thecore 206 proximally with respect to theelongated member 102, as shown inFIG. 20 . Alternatively, theelectrode 204 or thecore 206 may be spring biased to return to a configuration ofFIG. 20 when a constraining force is removed. This constraining force may be applied by a delivery sheath or bronchoscope through which theinventive device 326 is inserted or by a releasable catch. - The treatment of the tissue in the airway walls by transfer of energy according to the present invention provides improved long term relief from asthma symptoms for some asthma sufferers. However, over time, some amount of smooth muscle or mucus gland cells which were not affected by an initial treatment may regenerate and treatment may have to be repeated after a period of time such as one or more months or years.
- The airways which are treated with the device according to the present invention are preferably 1 mm in diameter or greater, more preferably 3 mm in diameter. The devices are preferably used to treat airways of the second to eighth generation, more preferably airways of the second to sixth generation.
- Although the present invention has been described in detail with respect to devices for the treatment of airways in the lungs, it should be understood that the present invention may also be used for treatment of other body conduits. For example, the treatment system may be used for reducing smooth muscle and spasms of the esophagus of patients with achalasia or esophageal spasm, in coronary arteries of patients with Printzmetal's angina variant, for ureteral spasm, for urethral spasm, and irritable bowel disorders.
- The devices and method describe herein provide a more effective and/or permanent treatment for asthma than the currently used bronchodilating drugs, drugs for reducing mucus secretion, and drugs for decreasing inflammation.
- Moreover, the inventive device may also include a steering member configured to guide the device to a desired target location. For example, this steering member may deflect a distal tip of the device in a desired direction to navigate to a desired bronchi or bronchiole. Also contemplated it the use of the device with a vision system. Such a vision system may comprise a fiber optic cable which allows a user of the device to guide a distal tip of the device to its desired location. The vision system may include a CCD chip.
- Also contemplated as the inventive device is the use of a power supply for providing energy as described above. The power supply provides the energy to be delivered to airway tissue via the energy transfer device. While the main goal of the power supply is to deliver enough energy to produce the desired effect, the power supply must also deliver the energy for a sufficient duration such that the effect persists. This is accomplished by a time setting which may be entered into the power supply memory by a user.
- A power supply may also include circuitry for monitoring parameters of energy transfer: (for example, voltage, current, power, impedance, as well as temperature from the temperature sensing element), and use this information to control the amount of energy delivered.
- A power supply may also include control modes for delivering energy safely and effectively. Energy may be delivered in open loop power control mode for a specific time duration. Energy may also be delivered in temperature control mode, with output power varied to maintain a certain temperature for a specific time duration. In the case of RF energy delivery via RF electrodes, the power supply may operate in impedance control mode.
- In temperature control mode with RF electrodes described here, the power supply will operate at up to a 75° C. setting. The duration must be long enough to produce the desired effect, but as short as possible to allow treatment of all of the desired target airways within a lung. For example, 5 to 10 seconds per activation (while the device is stationary) is preferred. Shorter duration with higher temperature will also produce acceptable acute effect.
- Using RF electrodes as described above in power control mode, power ranges of 10-15 W with durations of 3-5 seconds are preferred but may be varied. It should be noted that different device constructions utilize different parameter settings to achieve the desired effect. For example, while direct RF electrodes typically utilize temperatures up to 75° C. in temperature control mode, the resistively heated electrodes may utilize temperatures up to 90° C. Also, in addition to the control nodes specified above, the power supply may include control algorithms to limit excessive thermal damage to the airway tissue. For example, in order to stop delivery of energy in the event of contact between airway tissue and device legs having temperature sensing capabilities, an algorithm may be employed to shut down energy delivery if the sensed temperature does not rise by a certain number of degrees in a pre-specified amount of time after energy delivery begins. Another way to stop energy delivery includes shutting down a power supply if the temperature ramp is not within a predefined rage at any time during energy delivery. Other algorithms include shutting down a power supply if a maximum temperature setting is exceeded or shutting down a power supply if the sensed temperature suddenly changes, such a change includes either a drop or rise, this change may indicate failure of the temperature sensing element.
- Moreover, a variation of the invention includes configuring each energy exchange element independently to provide selective energy transfer radially about the device. As discussed above, another variation of the invention includes providing feedback control to determine the impedance of the airway to determine the power required by a power supply. Again, as discussed above, the feedback control could also be used to determine the size of the airway in which the device is positioned.
- Further details as to the use or other variation of the apparatus described herein may be drawn from the background which is intended to form part of the present invention. It is noted that this invention has been described and specific examples of the invention have been portrayed to convey a proper understanding of the invention. The use of such examples is not intended to limit the invention in any way. Additionally, to the extent that there are variations of the invention which are within the spirit of the disclosure and are equivalent to features found in the claims, it is the intent that the claims cover those variations as well. All equivalents are considered to be within the scope of the claimed invention, even those which may not have been set forth herein merely for the sake of brevity. Also, the various aspects of the invention described herein may be modified and/or used in combination with such other aspects also described to be part of the invention either explicitly or inherently to form other advantageous variations considered to be part of the invention covered by the claims which follow.
Claims (24)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/206,591 US20090069797A1 (en) | 1997-04-07 | 2008-09-08 | Bipolar devices for modification of airways by transfer of energy |
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/833,550 US6273907B1 (en) | 1997-04-07 | 1997-04-07 | Bronchial stenter |
US08/994,064 US6083255A (en) | 1997-04-07 | 1997-12-19 | Bronchial stenter |
US09/003,750 US5972026A (en) | 1997-04-07 | 1998-01-07 | Bronchial stenter having diametrically adjustable electrodes |
US9532398A | 1998-06-10 | 1998-06-10 | |
US09/224,937 US6200333B1 (en) | 1997-04-07 | 1998-12-31 | Bronchial stenter |
US09/260,401 US6283988B1 (en) | 1997-04-07 | 1999-03-01 | Bronchial stenter having expandable electrodes |
US09/296,040 US6411852B1 (en) | 1997-04-07 | 1999-04-21 | Modification of airways by application of energy |
US09/349,715 US6488673B1 (en) | 1997-04-07 | 1999-07-08 | Method of increasing gas exchange of a lung |
US09/436,455 US7425212B1 (en) | 1998-06-10 | 1999-11-08 | Devices for modification of airways by transfer of energy |
US10/232,909 US7556624B2 (en) | 1997-04-07 | 2002-08-30 | Method of increasing gas exchange of a lung |
US12/206,591 US20090069797A1 (en) | 1997-04-07 | 2008-09-08 | Bipolar devices for modification of airways by transfer of energy |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/436,455 Continuation US7425212B1 (en) | 1997-04-07 | 1999-11-08 | Devices for modification of airways by transfer of energy |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090069797A1 true US20090069797A1 (en) | 2009-03-12 |
Family
ID=39743202
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/436,455 Expired - Fee Related US7425212B1 (en) | 1997-04-07 | 1999-11-08 | Devices for modification of airways by transfer of energy |
US12/206,591 Abandoned US20090069797A1 (en) | 1997-04-07 | 2008-09-08 | Bipolar devices for modification of airways by transfer of energy |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/436,455 Expired - Fee Related US7425212B1 (en) | 1997-04-07 | 1999-11-08 | Devices for modification of airways by transfer of energy |
Country Status (1)
Country | Link |
---|---|
US (2) | US7425212B1 (en) |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060137698A1 (en) * | 1998-06-10 | 2006-06-29 | Asthmatx, Inc. | Methods for treating airways |
US20060247619A1 (en) * | 2004-11-05 | 2006-11-02 | Asthmatx, Inc. | Medical device with procedure improvement features |
US20070100390A1 (en) * | 2000-10-17 | 2007-05-03 | Asthmatx, Inc. | Modification of airways by application of energy |
US20070106296A1 (en) * | 1997-04-07 | 2007-05-10 | Asthmatx, Inc. | Expandable electode devices and methods of treating bronchial tubes |
US20070106292A1 (en) * | 2004-11-05 | 2007-05-10 | Asthmatx, Inc. | Energy delivery devices and methods |
US20070123961A1 (en) * | 2004-11-12 | 2007-05-31 | Asthmax, Inc. | Energy delivery and illumination devices and methods |
US20070123958A1 (en) * | 1998-06-10 | 2007-05-31 | Asthmatx, Inc. | Apparatus for treating airways in the lung |
US20090143705A1 (en) * | 1997-04-07 | 2009-06-04 | Asthmatx, Inc. | Modification of airways by application of ultrasound energy |
US20100160906A1 (en) * | 2008-12-23 | 2010-06-24 | Asthmatx, Inc. | Expandable energy delivery devices having flexible conductive elements and associated systems and methods |
US7837679B2 (en) | 2000-10-17 | 2010-11-23 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
US7921855B2 (en) | 1998-01-07 | 2011-04-12 | Asthmatx, Inc. | Method for treating an asthma attack |
US7931647B2 (en) | 2006-10-20 | 2011-04-26 | Asthmatx, Inc. | Method of delivering energy to a lung airway using markers |
US7992572B2 (en) | 1998-06-10 | 2011-08-09 | Asthmatx, Inc. | Methods of evaluating individuals having reversible obstructive pulmonary disease |
US8088127B2 (en) | 2008-05-09 | 2012-01-03 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8172827B2 (en) | 2003-05-13 | 2012-05-08 | Innovative Pulmonary Solutions, Inc. | Apparatus for treating asthma using neurotoxin |
US20120116378A1 (en) * | 2010-04-26 | 2012-05-10 | Minerva Surgical, Inc. | Endometrial ablation with a device that conforms to symmetric or asymmetric uterine cavities |
US8235983B2 (en) * | 2007-07-12 | 2012-08-07 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
US8251070B2 (en) | 2000-03-27 | 2012-08-28 | Asthmatx, Inc. | Methods for treating airways |
US8443810B2 (en) | 1998-06-10 | 2013-05-21 | Asthmatx, Inc. | Methods of reducing mucus in airways |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
US8740895B2 (en) | 2009-10-27 | 2014-06-03 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US20150265458A1 (en) * | 2014-02-21 | 2015-09-24 | Circuit Therapeutics, Inc. | System and method for therapeutic management of unproductive cough |
US9149328B2 (en) | 2009-11-11 | 2015-10-06 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US9272132B2 (en) | 2012-11-02 | 2016-03-01 | Boston Scientific Scimed, Inc. | Medical device for treating airways and related methods of use |
US9283374B2 (en) | 2012-11-05 | 2016-03-15 | Boston Scientific Scimed, Inc. | Devices and methods for delivering energy to body lumens |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
US9592086B2 (en) | 2012-07-24 | 2017-03-14 | Boston Scientific Scimed, Inc. | Electrodes for tissue treatment |
US9770293B2 (en) | 2012-06-04 | 2017-09-26 | Boston Scientific Scimed, Inc. | Systems and methods for treating tissue of a passageway within a body |
US9814618B2 (en) | 2013-06-06 | 2017-11-14 | Boston Scientific Scimed, Inc. | Devices for delivering energy and related methods of use |
CN107374725A (en) * | 2017-08-31 | 2017-11-24 | 苏州信迈医疗器械有限公司 | A kind of multipole ablating device |
US10478247B2 (en) | 2013-08-09 | 2019-11-19 | Boston Scientific Scimed, Inc. | Expandable catheter and related methods of manufacture and use |
CN111227929A (en) * | 2018-11-29 | 2020-06-05 | 上海安臻医疗科技有限公司 | Adjustable bronchus thermoforming pipe |
US10702337B2 (en) | 2016-06-27 | 2020-07-07 | Galary, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
US10858735B2 (en) | 2014-09-10 | 2020-12-08 | Applied Materials, Inc. | Alignment systems employing actuators providing relative displacement between lid assemblies of process chambers and substrates, and related methods |
CN112315410A (en) * | 2019-08-05 | 2021-02-05 | 卡尔史托斯股份有限公司 | Endoscope device |
Families Citing this family (132)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7425212B1 (en) * | 1998-06-10 | 2008-09-16 | Asthmatx, Inc. | Devices for modification of airways by transfer of energy |
AU780278B2 (en) | 1999-11-16 | 2005-03-10 | Covidien Lp | System and method of treating abnormal tissue in the human esophagus |
US20060095032A1 (en) | 1999-11-16 | 2006-05-04 | Jerome Jackson | Methods and systems for determining physiologic characteristics for treatment of the esophagus |
US20040215235A1 (en) | 1999-11-16 | 2004-10-28 | Barrx, Inc. | Methods and systems for determining physiologic characteristics for treatment of the esophagus |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US6752767B2 (en) | 2002-04-16 | 2004-06-22 | Vivant Medical, Inc. | Localization element with energized tip |
US20040082859A1 (en) | 2002-07-01 | 2004-04-29 | Alan Schaer | Method and apparatus employing ultrasound energy to treat body sphincters |
EP3045136B1 (en) | 2003-09-12 | 2021-02-24 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US7150745B2 (en) * | 2004-01-09 | 2006-12-19 | Barrx Medical, Inc. | Devices and methods for treatment of luminal tissue |
US8920414B2 (en) | 2004-09-10 | 2014-12-30 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
ES2645340T3 (en) | 2004-11-16 | 2017-12-05 | Uptake Medical Technology Inc. | Lung treatment device |
CN101076290B (en) | 2004-12-09 | 2011-11-23 | 铸造品股份有限公司 | Aortic valve repair |
EP2438877B1 (en) | 2005-03-28 | 2016-02-17 | Vessix Vascular, Inc. | Intraluminal electrical tissue characterization and tuned RF energy for selective treatment of atheroma and other target tissues |
JP4958896B2 (en) | 2005-04-21 | 2012-06-20 | アスマティックス,インコーポレイテッド | Control method and apparatus for energy delivery |
US7959627B2 (en) * | 2005-11-23 | 2011-06-14 | Barrx Medical, Inc. | Precision ablating device |
US7997278B2 (en) | 2005-11-23 | 2011-08-16 | Barrx Medical, Inc. | Precision ablating method |
US8702694B2 (en) | 2005-11-23 | 2014-04-22 | Covidien Lp | Auto-aligning ablating device and method of use |
AU2007245051A1 (en) * | 2006-03-31 | 2007-11-08 | Cook Medical Technologies Llc | Electrosurgical cutting device |
US9814519B2 (en) * | 2006-04-20 | 2017-11-14 | Boston Scientific Scimed, Inc. | Ablation probe with ribbed insulated sheath |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
AU2007310991B2 (en) | 2006-10-18 | 2013-06-20 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
ES2560006T3 (en) | 2006-10-18 | 2016-02-17 | Vessix Vascular, Inc. | Induction of desirable temperature effects on body tissue |
US7993323B2 (en) | 2006-11-13 | 2011-08-09 | Uptake Medical Corp. | High pressure and high temperature vapor catheters and systems |
US8496653B2 (en) | 2007-04-23 | 2013-07-30 | Boston Scientific Scimed, Inc. | Thrombus removal |
US8641711B2 (en) | 2007-05-04 | 2014-02-04 | Covidien Lp | Method and apparatus for gastrointestinal tract ablation for treatment of obesity |
US8784338B2 (en) * | 2007-06-22 | 2014-07-22 | Covidien Lp | Electrical means to normalize ablational energy transmission to a luminal tissue surface of varying size |
US8251992B2 (en) * | 2007-07-06 | 2012-08-28 | Tyco Healthcare Group Lp | Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight-loss operation |
BRPI0813579A2 (en) | 2007-07-06 | 2014-12-30 | Barrx Medical Inc | Methods for treating a bleeding area in a gastrointestinal tract and ablatively treating a target site within a bleeding area of a gastrointestinal tract and ablation system. |
US8273012B2 (en) * | 2007-07-30 | 2012-09-25 | Tyco Healthcare Group, Lp | Cleaning device and methods |
US8646460B2 (en) | 2007-07-30 | 2014-02-11 | Covidien Lp | Cleaning device and methods |
US8322335B2 (en) | 2007-10-22 | 2012-12-04 | Uptake Medical Corp. | Determining patient-specific vapor treatment and delivery parameters |
US8292880B2 (en) | 2007-11-27 | 2012-10-23 | Vivant Medical, Inc. | Targeted cooling of deployable microwave antenna |
EP2334365B1 (en) * | 2008-09-22 | 2016-10-26 | Boston Scientific Scimed, Inc. | Biasing a catheter balloon |
WO2010056745A1 (en) | 2008-11-17 | 2010-05-20 | Minnow Medical, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
WO2010080886A1 (en) | 2009-01-09 | 2010-07-15 | Recor Medical, Inc. | Methods and apparatus for treatment of mitral valve in insufficiency |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
US8323275B2 (en) | 2009-06-19 | 2012-12-04 | Vivant Medical, Inc. | Laparoscopic port with microwave rectifier |
US8672938B2 (en) * | 2009-07-23 | 2014-03-18 | Covidien Lp | Active cooling system and apparatus for controlling temperature of a fluid used during treatment of biological tissue |
US9113927B2 (en) | 2010-01-29 | 2015-08-25 | Covidien Lp | Apparatus and methods of use for treating blood vessels |
CA2795229A1 (en) | 2010-04-09 | 2011-10-13 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
WO2012100095A1 (en) | 2011-01-19 | 2012-07-26 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US10278774B2 (en) | 2011-03-18 | 2019-05-07 | Covidien Lp | Selectively expandable operative element support structure and methods of use |
EP2694150A1 (en) | 2011-04-08 | 2014-02-12 | Covidien LP | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
EP2701623B1 (en) | 2011-04-25 | 2016-08-17 | Medtronic Ardian Luxembourg S.à.r.l. | Apparatus related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
CN103813745B (en) | 2011-07-20 | 2016-06-29 | 波士顿科学西美德公司 | In order to visualize, be directed at and to melt transcutaneous device and the method for nerve |
WO2013016203A1 (en) | 2011-07-22 | 2013-01-31 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
WO2013055826A1 (en) | 2011-10-10 | 2013-04-18 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
EP2765940B1 (en) | 2011-10-11 | 2015-08-26 | Boston Scientific Scimed, Inc. | Off-wall electrode device for nerve modulation |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
WO2013059202A1 (en) | 2011-10-18 | 2013-04-25 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9486243B2 (en) | 2011-11-08 | 2016-11-08 | Covidien Lp | Systems and methods for treatment of premenstrual dysphoric disorders |
CN104023662B (en) | 2011-11-08 | 2018-02-09 | 波士顿科学西美德公司 | Hole portion renal nerve melts |
WO2013074813A1 (en) | 2011-11-15 | 2013-05-23 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
US9174050B2 (en) | 2011-12-23 | 2015-11-03 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
EP2797534A1 (en) | 2011-12-28 | 2014-11-05 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
WO2013169927A1 (en) | 2012-05-08 | 2013-11-14 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
JP5756568B2 (en) | 2012-05-31 | 2015-07-29 | カラー セブン カンパニー、リミテッド | Human body smooth muscle relaxation device |
CN104540465A (en) | 2012-08-24 | 2015-04-22 | 波士顿科学西美德公司 | Intravascular catheter with a balloon comprising separate microporous regions |
WO2014043687A2 (en) | 2012-09-17 | 2014-03-20 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
WO2014047454A2 (en) | 2012-09-21 | 2014-03-27 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US9522033B2 (en) | 2012-10-02 | 2016-12-20 | Covidien Lp | Devices and methods for optical detection of tissue contact |
US9668802B2 (en) | 2012-10-02 | 2017-06-06 | Covidien Lp | Devices and methods for optical detection of tissue contact |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US20140257130A1 (en) * | 2013-03-11 | 2014-09-11 | Boston Scientific Scimed, Inc. | Powered pull wire design for ablation catheters |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
JP6220044B2 (en) | 2013-03-15 | 2017-10-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
JP6139772B2 (en) | 2013-03-15 | 2017-05-31 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Control unit for use with electrode pads and method for estimating leakage |
CN105473091B (en) | 2013-06-21 | 2020-01-21 | 波士顿科学国际有限公司 | Renal denervation balloon catheter with co-movable electrode supports |
WO2014205399A1 (en) | 2013-06-21 | 2014-12-24 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US20140378968A1 (en) * | 2013-06-21 | 2014-12-25 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
JP6204579B2 (en) | 2013-07-01 | 2017-09-27 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Renal nerve ablation medical device |
CN105377169B (en) | 2013-07-11 | 2019-04-19 | 波士顿科学国际有限公司 | Device and method for neuromodulation |
EP3019106A1 (en) | 2013-07-11 | 2016-05-18 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
WO2015010074A1 (en) | 2013-07-19 | 2015-01-22 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US10342609B2 (en) | 2013-07-22 | 2019-07-09 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
CN105392435B (en) | 2013-07-22 | 2018-11-09 | 波士顿科学国际有限公司 | Renal nerve ablation catheter with twisting sacculus |
CN105473093B (en) | 2013-08-22 | 2019-02-05 | 波士顿科学国际有限公司 | Flexible circuit with the improved adhesion strength to renal nerve modulation sacculus |
CN105555218B (en) | 2013-09-04 | 2019-01-15 | 波士顿科学国际有限公司 | With radio frequency (RF) foley's tube rinsed with cooling capacity |
EP3043733A1 (en) | 2013-09-13 | 2016-07-20 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US9782211B2 (en) | 2013-10-01 | 2017-10-10 | Uptake Medical Technology Inc. | Preferential volume reduction of diseased segments of a heterogeneous lobe |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
WO2015057521A1 (en) | 2013-10-14 | 2015-04-23 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
JP6259098B2 (en) | 2013-10-15 | 2018-01-10 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device and method for manufacturing the medical device |
EP3057521B1 (en) | 2013-10-18 | 2020-03-25 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires |
WO2015061457A1 (en) | 2013-10-25 | 2015-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
CN105899157B (en) | 2014-01-06 | 2019-08-09 | 波士顿科学国际有限公司 | Tear-proof flexible circuit assembly |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
WO2015119890A1 (en) | 2014-02-04 | 2015-08-13 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US9579149B2 (en) | 2014-03-13 | 2017-02-28 | Medtronic Ardian Luxembourg S.A.R.L. | Low profile catheter assemblies and associated systems and methods |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US10398488B2 (en) * | 2014-09-04 | 2019-09-03 | Medtronic Cryocath Lp | Cryoadhesive device for left atrial appendage occlusion |
US10485604B2 (en) | 2014-12-02 | 2019-11-26 | Uptake Medical Technology Inc. | Vapor treatment of lung nodules and tumors |
US10531906B2 (en) | 2015-02-02 | 2020-01-14 | Uptake Medical Technology Inc. | Medical vapor generator |
US11129673B2 (en) | 2017-05-05 | 2021-09-28 | Uptake Medical Technology Inc. | Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD |
US11344364B2 (en) | 2017-09-07 | 2022-05-31 | Uptake Medical Technology Inc. | Screening method for a target nerve to ablate for the treatment of inflammatory lung disease |
US11350988B2 (en) | 2017-09-11 | 2022-06-07 | Uptake Medical Technology Inc. | Bronchoscopic multimodality lung tumor treatment |
USD845467S1 (en) | 2017-09-17 | 2019-04-09 | Uptake Medical Technology Inc. | Hand-piece for medical ablation catheter |
US11419658B2 (en) | 2017-11-06 | 2022-08-23 | Uptake Medical Technology Inc. | Method for treating emphysema with condensable thermal vapor |
US11490946B2 (en) | 2017-12-13 | 2022-11-08 | Uptake Medical Technology Inc. | Vapor ablation handpiece |
US11457977B2 (en) * | 2019-02-08 | 2022-10-04 | Shanghai Golden Leaf Medtech Co., Ltd. | Method for treating diabetes, diabetes-associated condition or disorder, or symptoms thereof |
US11653927B2 (en) | 2019-02-18 | 2023-05-23 | Uptake Medical Technology Inc. | Vapor ablation treatment of obstructive lung disease |
Citations (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1216183A (en) * | 1916-09-18 | 1917-02-13 | Charles M Swingle | Electrotherapeutic rejuvenator. |
US3597612A (en) * | 1969-01-27 | 1971-08-03 | Atomic Energy Commission | Power-pulse monitoring probe |
US4502490A (en) * | 1980-10-28 | 1985-03-05 | Antec Systems Limited | Patient monitoring equipment, probe for use therewith, and method of measuring anesthesia based on oesophagal contractions |
US4503855A (en) * | 1981-12-31 | 1985-03-12 | Harald Maslanka | High frequency surgical snare electrode |
US4512762A (en) * | 1982-11-23 | 1985-04-23 | The Beth Israel Hospital Association | Method of treatment of atherosclerosis and a balloon catheter for same |
US4643186A (en) * | 1985-10-30 | 1987-02-17 | Rca Corporation | Percutaneous transluminal microwave catheter angioplasty |
US4646737A (en) * | 1983-06-13 | 1987-03-03 | Laserscope, Inc. | Localized heat applying medical device |
US4739759A (en) * | 1985-02-26 | 1988-04-26 | Concept, Inc. | Microprocessor controlled electrosurgical generator |
US4817586A (en) * | 1987-11-24 | 1989-04-04 | Nimbus Medical, Inc. | Percutaneous bloom pump with mixed-flow output |
US4895557A (en) * | 1987-12-07 | 1990-01-23 | Nimbus Medical, Inc. | Drive mechanism for powering intravascular blood pumps |
US4906229A (en) * | 1988-05-03 | 1990-03-06 | Nimbus Medical, Inc. | High-frequency transvalvular axisymmetric blood pump |
US4907589A (en) * | 1988-04-29 | 1990-03-13 | Cosman Eric R | Automatic over-temperature control apparatus for a therapeutic heating device |
US4908012A (en) * | 1988-08-08 | 1990-03-13 | Nimbus Medical, Inc. | Chronic ventricular assist system |
US4985014A (en) * | 1989-07-11 | 1991-01-15 | Orejola Wilmo C | Ventricular venting loop |
US4991603A (en) * | 1989-10-30 | 1991-02-12 | Siemens-Pacesetter, Inc. | Transvenously placed defibrillation leads via an inferior vena cava access site and method of use |
US5009636A (en) * | 1989-12-06 | 1991-04-23 | The Kendall Company | Dual-lumen catheter apparatus and method |
US5009936A (en) * | 1988-09-02 | 1991-04-23 | Nissan Motor Co., Ltd. | Method for forming tranparent multilayers |
US5010892A (en) * | 1988-05-04 | 1991-04-30 | Triangle Research And Development Corp. | Body lumen measuring instrument |
US5078716A (en) * | 1990-05-11 | 1992-01-07 | Doll Larry F | Electrosurgical apparatus for resecting abnormal protruding growth |
US5106360A (en) * | 1987-09-17 | 1992-04-21 | Olympus Optical Co., Ltd. | Thermotherapeutic apparatus |
US5105826A (en) * | 1990-10-26 | 1992-04-21 | Medtronic, Inc. | Implantable defibrillation electrode and method of manufacture |
US5107830A (en) * | 1987-02-21 | 1992-04-28 | University Of Manitoba | Lung ventilator device |
US5188602A (en) * | 1990-07-12 | 1993-02-23 | Interventional Thermodynamics, Inc. | Method and device for delivering heat to hollow body organs |
US5277201A (en) * | 1992-05-01 | 1994-01-11 | Vesta Medical, Inc. | Endometrial ablation apparatus and method |
US5292331A (en) * | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
US5376094A (en) * | 1993-08-19 | 1994-12-27 | Boston Scientific Corporation | Improved actuating handle with pulley system for providing mechanical advantage to a surgical working element |
WO1995002370A2 (en) * | 1993-07-15 | 1995-01-26 | Aws Shakir Mustafa Salim | Tunnelling catheter |
US5393207A (en) * | 1993-01-21 | 1995-02-28 | Nimbus, Inc. | Blood pump with disposable rotor assembly |
US5400778A (en) * | 1990-06-18 | 1995-03-28 | Siemens-Elema Ab | Method and device for reduction of rebreathing of gas from dead space |
US5496271A (en) * | 1990-09-14 | 1996-03-05 | American Medical Systems, Inc. | Combined hyperthermia and dilation catheter |
US5496312A (en) * | 1993-10-07 | 1996-03-05 | Valleylab Inc. | Impedance and temperature generator control |
US5505730A (en) * | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
US5507791A (en) * | 1993-08-31 | 1996-04-16 | Sit'ko; Sergei P. | Microwave resonance therapy |
US5599345A (en) * | 1993-11-08 | 1997-02-04 | Zomed International, Inc. | RF treatment apparatus |
US5623940A (en) * | 1994-08-02 | 1997-04-29 | S.L.T. Japan Co., Ltd. | Catheter apparatus with a sensor |
WO1997032532A1 (en) * | 1996-03-05 | 1997-09-12 | Vnus Medical Technologies, Inc. | Vascular catheter-based system for heating tissue |
US5707336A (en) * | 1995-01-09 | 1998-01-13 | Cardassist Incorporated | Ventricular assist device |
US5707218A (en) * | 1995-04-19 | 1998-01-13 | Nimbus, Inc. | Implantable electric axial-flow blood pump with blood cooled bearing |
US5727569A (en) * | 1996-02-20 | 1998-03-17 | Cardiothoracic Systems, Inc. | Surgical devices for imposing a negative pressure to fix the position of cardiac tissue during surgery |
US5728094A (en) * | 1996-02-23 | 1998-03-17 | Somnus Medical Technologies, Inc. | Method and apparatus for treatment of air way obstructions |
US5730704A (en) * | 1992-02-24 | 1998-03-24 | Avitall; Boaz | Loop electrode array mapping and ablation catheter for cardiac chambers |
US5735846A (en) * | 1994-06-27 | 1998-04-07 | Ep Technologies, Inc. | Systems and methods for ablating body tissue using predicted maximum tissue temperature |
US5741248A (en) * | 1995-06-07 | 1998-04-21 | Temple University-Of The Commonwealth System Of Higher Education | Fluorochemical liquid augmented cryosurgery |
WO1999003413A1 (en) * | 1997-07-17 | 1999-01-28 | Vnus Medical Technologies, Inc. | Expandable catheter having improved electrode design, and method for applying energy |
US5873852A (en) * | 1995-07-10 | 1999-02-23 | Interventional Technologies | Device for injecting fluid into a wall of a blood vessel |
US5876399A (en) * | 1997-05-28 | 1999-03-02 | Irvine Biomedical, Inc. | Catheter system and methods thereof |
US5876340A (en) * | 1997-04-17 | 1999-03-02 | Irvine Biomedical, Inc. | Ablation apparatus with ultrasonic imaging capabilities |
US5891138A (en) * | 1997-08-11 | 1999-04-06 | Irvine Biomedical, Inc. | Catheter system having parallel electrodes |
US5891136A (en) * | 1996-01-19 | 1999-04-06 | Ep Technologies, Inc. | Expandable-collapsible mesh electrode structures |
US5891135A (en) * | 1996-01-19 | 1999-04-06 | Ep Technologies, Inc. | Stem elements for securing tubing and electrical wires to expandable-collapsible electrode structures |
US5893847A (en) * | 1993-03-16 | 1999-04-13 | Ep Technologies, Inc. | Multiple electrode support structures with slotted hub and hoop spline elements |
US6014579A (en) * | 1997-07-21 | 2000-01-11 | Cardiac Pathways Corp. | Endocardial mapping catheter with movable electrode |
US6023638A (en) * | 1995-07-28 | 2000-02-08 | Scimed Life Systems, Inc. | System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue |
US6029091A (en) * | 1998-07-09 | 2000-02-22 | Irvine Biomedical, Inc. | Catheter system having lattice electrodes |
US6033397A (en) * | 1996-03-05 | 2000-03-07 | Vnus Medical Technologies, Inc. | Method and apparatus for treating esophageal varices |
US6036689A (en) * | 1998-09-24 | 2000-03-14 | Tu; Lily Chen | Ablation device for treating atherosclerotic tissues |
US6039731A (en) * | 1995-06-09 | 2000-03-21 | Engineering & Research Associates, Inc. | Apparatus and method for determining the extent of ablation |
US6045549A (en) * | 1997-09-30 | 2000-04-04 | Somnus Medical Technologies, Inc. | Tissue ablation apparatus and device for use therein and method |
US6050992A (en) * | 1997-05-19 | 2000-04-18 | Radiotherapeutics Corporation | Apparatus and method for treating tissue with multiple electrodes |
US6053909A (en) * | 1998-03-27 | 2000-04-25 | Shadduck; John H. | Ionothermal delivery system and technique for medical procedures |
US6179833B1 (en) * | 1995-06-09 | 2001-01-30 | Engineering & Research Associates, Inc. | Apparatus for thermal ablation |
US6183468B1 (en) * | 1998-09-10 | 2001-02-06 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6200311B1 (en) * | 1998-01-20 | 2001-03-13 | Eclipse Surgical Technologies, Inc. | Minimally invasive TMR device |
US6200332B1 (en) * | 1999-07-09 | 2001-03-13 | Ceramoptec Industries, Inc. | Device and method for underskin laser treatments |
US6212433B1 (en) * | 1998-07-28 | 2001-04-03 | Radiotherapeutics Corporation | Method for treating tumors near the surface of an organ |
US6210367B1 (en) * | 1995-09-06 | 2001-04-03 | Microwave Medical Systems, Inc. | Intracorporeal microwave warming method and apparatus |
US6216043B1 (en) * | 1994-03-04 | 2001-04-10 | Ep Technologies, Inc. | Asymmetric multiple electrode support structures |
US6214002B1 (en) * | 1994-10-07 | 2001-04-10 | Ep Technologies, Inc. | Structures and methods for deploying electrode elements |
US6217576B1 (en) * | 1997-05-19 | 2001-04-17 | Irvine Biomedical Inc. | Catheter probe for treating focal atrial fibrillation in pulmonary veins |
US6338727B1 (en) * | 1998-08-13 | 2002-01-15 | Alsius Corporation | Indwelling heat exchange catheter and method of using same |
US6346104B2 (en) * | 1996-04-30 | 2002-02-12 | Western Sydney Area Health Service | System for simultaneous unipolar multi-electrode ablation |
US6355031B1 (en) * | 1998-02-19 | 2002-03-12 | Curon Medical, Inc. | Control systems for multiple electrode arrays to create lesions in tissue regions at or near a sphincter |
US6370644B1 (en) * | 1998-04-07 | 2002-04-09 | Micron Technology, Inc. | Device for blocking bus transactions during reset |
US6379352B1 (en) * | 1992-09-29 | 2002-04-30 | Ep Technologies, Inc. | Large surface cardiac ablation catherter that assumes a low profile during introduction into the heart |
US6514246B1 (en) * | 1993-10-14 | 2003-02-04 | Ep Technologies, Inc. | Systems and methods for forming large lesions in body tissue using curvilinear electrode elements |
US6526320B2 (en) * | 1998-11-16 | 2003-02-25 | United States Surgical Corporation | Apparatus for thermal treatment of tissue |
US6529756B1 (en) * | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
US20030050631A1 (en) * | 2000-12-29 | 2003-03-13 | Afx, Inc. | Tissue ablation apparatus with a sliding ablation instrument and method |
US20030065371A1 (en) * | 2001-09-28 | 2003-04-03 | Shutaro Satake | Radiofrequency thermal balloon catheter |
US6544226B1 (en) * | 2000-03-13 | 2003-04-08 | Curon Medical, Inc. | Operative devices that can be removably fitted on catheter bodies to treat tissue regions in the body |
US20030069570A1 (en) * | 1999-10-02 | 2003-04-10 | Witzel Thomas H. | Methods for repairing mitral valve annulus percutaneously |
US6547788B1 (en) * | 1997-07-08 | 2003-04-15 | Atrionx, Inc. | Medical device with sensor cooperating with expandable member |
US6673068B1 (en) * | 2000-04-12 | 2004-01-06 | Afx, Inc. | Electrode arrangement for use in a medical instrument |
US6689693B2 (en) * | 2000-08-30 | 2004-02-10 | Micron Technology, Inc. | Methods for utilization of disappearing silicon hard mask for fabrication of semiconductor structures |
US6692492B2 (en) * | 2001-11-28 | 2004-02-17 | Cardiac Pacemaker, Inc. | Dielectric-coated ablation electrode having a non-coated window with thermal sensors |
US20040031494A1 (en) * | 1998-06-10 | 2004-02-19 | Broncus Technologies, Inc. | Methods of treating asthma |
US6699243B2 (en) * | 2001-09-19 | 2004-03-02 | Curon Medical, Inc. | Devices, systems and methods for treating tissue regions of the body |
US6714822B2 (en) * | 1998-04-30 | 2004-03-30 | Medtronic, Inc. | Apparatus and method for expanding a stimulation lead body in situ |
US6723091B2 (en) * | 2000-02-22 | 2004-04-20 | Gyrus Medical Limited | Tissue resurfacing |
US6837888B2 (en) * | 1995-06-07 | 2005-01-04 | Arthrocare Corporation | Electrosurgical probe with movable return electrode and methods related thereto |
US6840243B2 (en) * | 2000-03-04 | 2005-01-11 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
US6849073B2 (en) * | 1998-07-07 | 2005-02-01 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US6852110B2 (en) * | 2002-08-01 | 2005-02-08 | Solarant Medical, Inc. | Needle deployment for temperature sensing from an electrode |
US6852091B2 (en) * | 1992-08-12 | 2005-02-08 | Medtronic Vidamed, Inc. | Medical probe device and method |
US6866662B2 (en) * | 2002-07-23 | 2005-03-15 | Biosense Webster, Inc. | Ablation catheter having stabilizing array |
US6881213B2 (en) * | 2002-06-28 | 2005-04-19 | Ethicon, Inc. | Device and method to expand treatment array |
US20060062808A1 (en) * | 2004-09-18 | 2006-03-23 | Asthmatx, Inc. | Inactivation of smooth muscle tissue |
US7186251B2 (en) * | 2003-03-27 | 2007-03-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
US20080004596A1 (en) * | 2006-05-25 | 2008-01-03 | Palo Alto Institute | Delivery of agents by microneedle catheter |
US7425212B1 (en) * | 1998-06-10 | 2008-09-16 | Asthmatx, Inc. | Devices for modification of airways by transfer of energy |
US20090018538A1 (en) * | 2007-07-12 | 2009-01-15 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
US20090030477A1 (en) * | 2007-07-24 | 2009-01-29 | Asthmatx, Inc. | System and method for controlling power based on impedance detection, such as controlling power to tissue treatment devices |
US20090043301A1 (en) * | 2007-08-09 | 2009-02-12 | Asthmatx, Inc. | Monopolar energy delivery devices and methods for controlling current density in tissue |
Family Cites Families (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1155169A (en) | 1914-11-28 | 1915-09-28 | John Starkweather | Surgical instrument. |
US1207479A (en) | 1915-03-05 | 1916-12-05 | Holger Bisgaard | Self-retaining gatheter. |
US2072346A (en) | 1934-10-04 | 1937-03-02 | Ward R Smith | Drainage tube |
US3568659A (en) | 1968-09-24 | 1971-03-09 | James N Karnegis | Disposable percutaneous intracardiac pump and method of pumping blood |
US3667476A (en) | 1970-04-27 | 1972-06-06 | Bio Data Corp | Apparatus for monitoring body temperature and controlling a heating device to maintain a selected temperature |
US3692029A (en) | 1971-05-03 | 1972-09-19 | Edwin Lloyd Adair | Retention catheter and suprapubic shunt |
US4565200A (en) | 1980-09-24 | 1986-01-21 | Cosman Eric R | Universal lesion and recording electrode system |
JPS57168656A (en) | 1981-04-10 | 1982-10-18 | Medos Kenkyusho Kk | Endoscope laser coagulator |
US4706688A (en) | 1981-05-18 | 1987-11-17 | Don Michael T Anthony | Non-invasive cardiac device |
US4612934A (en) | 1981-06-30 | 1986-09-23 | Borkan William N | Non-invasive multiprogrammable tissue stimulator |
US4584998A (en) | 1981-09-11 | 1986-04-29 | Mallinckrodt, Inc. | Multi-purpose tracheal tube |
US4567882A (en) | 1982-12-06 | 1986-02-04 | Vanderbilt University | Method for locating the illuminated tip of an endotracheal tube |
US4522212A (en) | 1983-11-14 | 1985-06-11 | Mansfield Scientific, Inc. | Endocardial electrode |
FR2561929B1 (en) | 1984-03-27 | 1989-02-03 | Atesys | IMPLANTED AUTOMATIC APPARATUS FOR VENTRICULAR DEFIBRILLATION |
JPS6148350A (en) | 1984-08-15 | 1986-03-10 | オリンパス光学工業株式会社 | Medical laser apparatus |
US5019075A (en) | 1984-10-24 | 1991-05-28 | The Beth Israel Hospital | Method and apparatus for angioplasty |
US4799479A (en) * | 1984-10-24 | 1989-01-24 | The Beth Israel Hospital Association | Method and apparatus for angioplasty |
EP0189329A3 (en) * | 1985-01-25 | 1987-06-03 | Robert E. Fischell | A tunneling catheter system for transluminal arterial angioplasty |
US4862886A (en) | 1985-05-08 | 1989-09-05 | Summit Technology Inc. | Laser angioplasty |
US4976709A (en) | 1988-12-15 | 1990-12-11 | Sand Bruce J | Method for collagen treatment |
US4827935A (en) | 1986-04-24 | 1989-05-09 | Purdue Research Foundation | Demand electroventilator |
US4709698A (en) | 1986-05-14 | 1987-12-01 | Thomas J. Fogarty | Heatable dilation catheter |
US5231995A (en) | 1986-11-14 | 1993-08-03 | Desai Jawahar M | Method for catheter mapping and ablation |
US5215103A (en) | 1986-11-14 | 1993-06-01 | Desai Jawahar M | Catheter for mapping and ablation and method therefor |
US4802492A (en) | 1987-03-11 | 1989-02-07 | National Jewish Center For Immunology And Respiratory Medicine | Method for determining respiratory function |
US5588432A (en) | 1988-03-21 | 1996-12-31 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials, and ablating tissue |
US4920978A (en) | 1988-08-31 | 1990-05-01 | Triangle Research And Development Corporation | Method and apparatus for the endoscopic treatment of deep tumors using RF hyperthermia |
US4955377A (en) | 1988-10-28 | 1990-09-11 | Lennox Charles D | Device and method for heating tissue in a patient's body |
US5191883A (en) | 1988-10-28 | 1993-03-09 | Prutech Research And Development Partnership Ii | Device for heating tissue in a patient's body |
US5433730A (en) | 1989-05-03 | 1995-07-18 | Intermedics, Inc. | Conductive pouch electrode for defibrillation |
US5152286A (en) | 1989-05-08 | 1992-10-06 | Mezhotraslevoi Nauchnoinzhenerny Tsentr "Vidguk" | Method of microwave resonance therapy and device therefor |
US5074860A (en) * | 1989-06-09 | 1991-12-24 | Heraeus Lasersonics, Inc. | Apparatus for directing 10.6 micron laser radiation to a tissue site |
US5084044A (en) | 1989-07-14 | 1992-01-28 | Ciron Corporation | Apparatus for endometrial ablation and method of using same |
US5057105A (en) | 1989-08-28 | 1991-10-15 | The University Of Kansas Med Center | Hot tip catheter assembly |
US5562608A (en) | 1989-08-28 | 1996-10-08 | Biopulmonics, Inc. | Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation |
CA2067110C (en) | 1989-09-08 | 2001-07-31 | John E. Abele | Physiologic low stress angioplasty |
US5100388A (en) | 1989-09-15 | 1992-03-31 | Interventional Thermodynamics, Inc. | Method and device for thermal ablation of hollow body organs |
US5117828A (en) | 1989-09-25 | 1992-06-02 | Arzco Medical Electronics, Inc. | Expandable esophageal catheter |
US5254088A (en) * | 1990-02-02 | 1993-10-19 | Ep Technologies, Inc. | Catheter steering mechanism |
US5549559A (en) | 1990-03-22 | 1996-08-27 | Argomed Ltd. | Thermal treatment apparatus |
US5096916A (en) | 1990-05-07 | 1992-03-17 | Aegis Technology, Inc. | Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline |
US5056519A (en) | 1990-05-14 | 1991-10-15 | Vince Dennis J | Unilateral diaphragmatic pacer |
US5265604A (en) | 1990-05-14 | 1993-11-30 | Vince Dennis J | Demand - diaphragmatic pacing (skeletal muscle pressure modified) |
US5103804A (en) | 1990-07-03 | 1992-04-14 | Boston Scientific Corporation | Expandable tip hemostatic probes and the like |
US5135517A (en) | 1990-07-19 | 1992-08-04 | Catheter Research, Inc. | Expandable tube-positioning apparatus |
US5100423A (en) | 1990-08-21 | 1992-03-31 | Medical Engineering & Development Institute, Inc. | Ablation catheter |
US5170803A (en) | 1990-09-28 | 1992-12-15 | Brunswick Biomedical Technologies, Inc. | Esophageal displacement electrode |
US5053033A (en) | 1990-10-10 | 1991-10-01 | Boston Advanced Technologies, Inc. | Inhibition of restenosis by ultraviolet radiation |
US5174288A (en) | 1990-11-30 | 1992-12-29 | Medtronic, Inc. | Method and apparatus for cardiac defibrillation |
US5465717A (en) | 1991-02-15 | 1995-11-14 | Cardiac Pathways Corporation | Apparatus and Method for ventricular mapping and ablation |
US5345936A (en) | 1991-02-15 | 1994-09-13 | Cardiac Pathways Corporation | Apparatus with basket assembly for endocardial mapping |
US5415166A (en) | 1991-02-15 | 1995-05-16 | Cardiac Pathways Corporation | Endocardial mapping apparatus and cylindrical semiconductor device mounting structure for use therewith and method |
US5116864A (en) | 1991-04-09 | 1992-05-26 | Indiana University Foundation | Method for preventing restenosis following reconfiguration of body vessels |
WO1992020401A1 (en) | 1991-04-10 | 1992-11-26 | British Technology Group Usa, Inc. | Defibrillator and demand pacer catheter and method |
US5255678A (en) | 1991-06-21 | 1993-10-26 | Ecole Polytechnique | Mapping electrode balloon |
US5383917A (en) | 1991-07-05 | 1995-01-24 | Jawahar M. Desai | Device and method for multi-phase radio-frequency ablation |
US5540681A (en) | 1992-04-10 | 1996-07-30 | Medtronic Cardiorhythm | Method and system for radiofrequency ablation of tissue |
US5269758A (en) | 1992-04-29 | 1993-12-14 | Taheri Syde A | Intravascular catheter and method for treatment of hypothermia |
US5443470A (en) | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Method and apparatus for endometrial ablation |
US5255679A (en) | 1992-06-02 | 1993-10-26 | Cardiac Pathways Corporation | Endocardial catheter for mapping and/or ablation with an expandable basket structure having means for providing selective reinforcement and pressure sensing mechanism for use therewith, and method |
US5281218A (en) | 1992-06-05 | 1994-01-25 | Cardiac Pathways Corporation | Catheter having needle electrode for radiofrequency ablation |
US5411025A (en) | 1992-06-30 | 1995-05-02 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array |
GB9219102D0 (en) | 1992-09-09 | 1992-10-21 | Fairfax Andrew J | Flowmeters |
US5313943A (en) | 1992-09-25 | 1994-05-24 | Ep Technologies, Inc. | Catheters and methods for performing cardiac diagnosis and treatment |
US5293869A (en) | 1992-09-25 | 1994-03-15 | Ep Technologies, Inc. | Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole |
US5309910A (en) * | 1992-09-25 | 1994-05-10 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
US5471982A (en) | 1992-09-29 | 1995-12-05 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
EP0669839B2 (en) | 1992-10-01 | 2001-12-19 | Cardiac Pacemakers, Inc. | Stent-type defibrillation electrode structures |
US5431696A (en) | 1992-10-13 | 1995-07-11 | Atlee, Iii; John L. | Esophageal probe for transeophageal cardiac stimulation |
US5545161A (en) | 1992-12-01 | 1996-08-13 | Cardiac Pathways Corporation | Catheter for RF ablation having cooled electrode with electrically insulated sleeve |
US5348554A (en) | 1992-12-01 | 1994-09-20 | Cardiac Pathways Corporation | Catheter for RF ablation with cooled electrode |
US5256141A (en) | 1992-12-22 | 1993-10-26 | Nelson Gencheff | Biological material deployment method and apparatus |
US5725525A (en) * | 1993-03-16 | 1998-03-10 | Ep Technologies, Inc. | Multiple electrode support structures with integral hub and spline elements |
ATE194469T1 (en) * | 1993-03-16 | 2000-07-15 | Ep Technologies | CARRIER ARRANGEMENT FOR MULTIPLE ELECTRODES |
US5417687A (en) | 1993-04-30 | 1995-05-23 | Medical Scientific, Inc. | Bipolar electrosurgical trocar |
US5456667A (en) | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
US5396887A (en) | 1993-09-23 | 1995-03-14 | Cardiac Pathways Corporation | Apparatus and method for detecting contact pressure |
US5607462A (en) | 1993-09-24 | 1997-03-04 | Cardiac Pathways Corporation | Catheter assembly, catheter and multi-catheter introducer for use therewith |
US5626618A (en) | 1993-09-24 | 1997-05-06 | The Ohio State University | Mechanical adjunct to cardiopulmonary resuscitation (CPR), and an electrical adjunct to defibrillation countershock, cardiac pacing, and cardiac monitoring |
US5415656A (en) | 1993-09-28 | 1995-05-16 | American Medical Systems, Inc. | Electrosurgical apparatus |
US5400783A (en) | 1993-10-12 | 1995-03-28 | Cardiac Pathways Corporation | Endocardial mapping apparatus with rotatable arm and method |
US5545193A (en) | 1993-10-15 | 1996-08-13 | Ep Technologies, Inc. | Helically wound radio-frequency emitting electrodes for creating lesions in body tissue |
US5423812A (en) | 1994-01-31 | 1995-06-13 | Ellman; Alan G. | Electrosurgical stripping electrode for palatopharynx tissue |
US5394880A (en) | 1994-03-17 | 1995-03-07 | Atlee, Iii; John L. | Esophageal stethoscope |
US5598848A (en) | 1994-03-31 | 1997-02-04 | Ep Technologies, Inc. | Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium |
US5458596A (en) | 1994-05-06 | 1995-10-17 | Dorsal Orthopedic Corporation | Method and apparatus for controlled contraction of soft tissue |
US5478309A (en) | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
US5681308A (en) | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
US5680860A (en) | 1994-07-07 | 1997-10-28 | Cardiac Pathways Corporation | Mapping and/or ablation catheter with coilable distal extremity and method for using same |
US5454782A (en) | 1994-08-11 | 1995-10-03 | Perkins; Rodney C. | Translumenal circumferential energy delivery device |
US5549655A (en) | 1994-09-21 | 1996-08-27 | Medtronic, Inc. | Method and apparatus for synchronized treatment of obstructive sleep apnea |
US5522862A (en) | 1994-09-21 | 1996-06-04 | Medtronic, Inc. | Method and apparatus for treating obstructive sleep apnea |
US5836947A (en) * | 1994-10-07 | 1998-11-17 | Ep Technologies, Inc. | Flexible structures having movable splines for supporting electrode elements |
US5899882A (en) * | 1994-10-27 | 1999-05-04 | Novoste Corporation | Catheter apparatus for radiation treatment of a desired area in the vascular system of a patient |
US5605157A (en) | 1995-02-17 | 1997-02-25 | Ep Technologies, Inc. | Systems and methods for filtering signals derived from biological events |
US5601088A (en) | 1995-02-17 | 1997-02-11 | Ep Technologies, Inc. | Systems and methods for filtering artifacts from composite signals |
US5630425A (en) | 1995-02-17 | 1997-05-20 | Ep Technologies, Inc. | Systems and methods for adaptive filtering artifacts from composite signals |
US5595183A (en) | 1995-02-17 | 1997-01-21 | Ep Technologies, Inc. | Systems and methods for examining heart tissue employing multiple electrode structures and roving electrodes |
US5620438A (en) | 1995-04-20 | 1997-04-15 | Angiomedics Ii Incorporated | Method and apparatus for treating vascular tissue following angioplasty to minimize restenosis |
US5678535A (en) | 1995-04-21 | 1997-10-21 | Dimarco; Anthony Fortunato | Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient |
US5607419A (en) | 1995-04-24 | 1997-03-04 | Angiomedics Ii Inc. | Method and apparatus for treating vessel wall with UV radiation following angioplasty |
US5624439A (en) | 1995-08-18 | 1997-04-29 | Somnus Medical Technologies, Inc. | Method and apparatus for treatment of air way obstructions |
US5846238A (en) * | 1996-01-19 | 1998-12-08 | Ep Technologies, Inc. | Expandable-collapsible electrode structures with distal end steering or manipulation |
US5699799A (en) | 1996-03-26 | 1997-12-23 | Siemens Corporate Research, Inc. | Automatic determination of the curved axis of a 3-D tube-shaped object in image volume |
US6056769A (en) * | 1997-02-11 | 2000-05-02 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method |
US6071281A (en) * | 1998-05-05 | 2000-06-06 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same |
-
1999
- 1999-11-08 US US09/436,455 patent/US7425212B1/en not_active Expired - Fee Related
-
2008
- 2008-09-08 US US12/206,591 patent/US20090069797A1/en not_active Abandoned
Patent Citations (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1216183A (en) * | 1916-09-18 | 1917-02-13 | Charles M Swingle | Electrotherapeutic rejuvenator. |
US3597612A (en) * | 1969-01-27 | 1971-08-03 | Atomic Energy Commission | Power-pulse monitoring probe |
US4502490A (en) * | 1980-10-28 | 1985-03-05 | Antec Systems Limited | Patient monitoring equipment, probe for use therewith, and method of measuring anesthesia based on oesophagal contractions |
US4503855A (en) * | 1981-12-31 | 1985-03-12 | Harald Maslanka | High frequency surgical snare electrode |
US4512762A (en) * | 1982-11-23 | 1985-04-23 | The Beth Israel Hospital Association | Method of treatment of atherosclerosis and a balloon catheter for same |
US4646737A (en) * | 1983-06-13 | 1987-03-03 | Laserscope, Inc. | Localized heat applying medical device |
US4739759A (en) * | 1985-02-26 | 1988-04-26 | Concept, Inc. | Microprocessor controlled electrosurgical generator |
US4643186A (en) * | 1985-10-30 | 1987-02-17 | Rca Corporation | Percutaneous transluminal microwave catheter angioplasty |
US5107830A (en) * | 1987-02-21 | 1992-04-28 | University Of Manitoba | Lung ventilator device |
US5106360A (en) * | 1987-09-17 | 1992-04-21 | Olympus Optical Co., Ltd. | Thermotherapeutic apparatus |
US4817586A (en) * | 1987-11-24 | 1989-04-04 | Nimbus Medical, Inc. | Percutaneous bloom pump with mixed-flow output |
US4895557A (en) * | 1987-12-07 | 1990-01-23 | Nimbus Medical, Inc. | Drive mechanism for powering intravascular blood pumps |
US4907589A (en) * | 1988-04-29 | 1990-03-13 | Cosman Eric R | Automatic over-temperature control apparatus for a therapeutic heating device |
US4906229A (en) * | 1988-05-03 | 1990-03-06 | Nimbus Medical, Inc. | High-frequency transvalvular axisymmetric blood pump |
US5010892A (en) * | 1988-05-04 | 1991-04-30 | Triangle Research And Development Corp. | Body lumen measuring instrument |
US4908012A (en) * | 1988-08-08 | 1990-03-13 | Nimbus Medical, Inc. | Chronic ventricular assist system |
US5009936A (en) * | 1988-09-02 | 1991-04-23 | Nissan Motor Co., Ltd. | Method for forming tranparent multilayers |
US4985014A (en) * | 1989-07-11 | 1991-01-15 | Orejola Wilmo C | Ventricular venting loop |
US5292331A (en) * | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
US4991603A (en) * | 1989-10-30 | 1991-02-12 | Siemens-Pacesetter, Inc. | Transvenously placed defibrillation leads via an inferior vena cava access site and method of use |
US5009636A (en) * | 1989-12-06 | 1991-04-23 | The Kendall Company | Dual-lumen catheter apparatus and method |
US5078716A (en) * | 1990-05-11 | 1992-01-07 | Doll Larry F | Electrosurgical apparatus for resecting abnormal protruding growth |
US5400778A (en) * | 1990-06-18 | 1995-03-28 | Siemens-Elema Ab | Method and device for reduction of rebreathing of gas from dead space |
US5188602A (en) * | 1990-07-12 | 1993-02-23 | Interventional Thermodynamics, Inc. | Method and device for delivering heat to hollow body organs |
US5496271A (en) * | 1990-09-14 | 1996-03-05 | American Medical Systems, Inc. | Combined hyperthermia and dilation catheter |
US5105826A (en) * | 1990-10-26 | 1992-04-21 | Medtronic, Inc. | Implantable defibrillation electrode and method of manufacture |
US5730704A (en) * | 1992-02-24 | 1998-03-24 | Avitall; Boaz | Loop electrode array mapping and ablation catheter for cardiac chambers |
US5277201A (en) * | 1992-05-01 | 1994-01-11 | Vesta Medical, Inc. | Endometrial ablation apparatus and method |
US6852091B2 (en) * | 1992-08-12 | 2005-02-08 | Medtronic Vidamed, Inc. | Medical probe device and method |
US6379352B1 (en) * | 1992-09-29 | 2002-04-30 | Ep Technologies, Inc. | Large surface cardiac ablation catherter that assumes a low profile during introduction into the heart |
US5393207A (en) * | 1993-01-21 | 1995-02-28 | Nimbus, Inc. | Blood pump with disposable rotor assembly |
US6216044B1 (en) * | 1993-03-16 | 2001-04-10 | Ep Technologies, Inc. | Medical device with three dimensional collapsible basket structure |
US5893847A (en) * | 1993-03-16 | 1999-04-13 | Ep Technologies, Inc. | Multiple electrode support structures with slotted hub and hoop spline elements |
WO1995002370A2 (en) * | 1993-07-15 | 1995-01-26 | Aws Shakir Mustafa Salim | Tunnelling catheter |
US5376094A (en) * | 1993-08-19 | 1994-12-27 | Boston Scientific Corporation | Improved actuating handle with pulley system for providing mechanical advantage to a surgical working element |
US5507791A (en) * | 1993-08-31 | 1996-04-16 | Sit'ko; Sergei P. | Microwave resonance therapy |
US5496312A (en) * | 1993-10-07 | 1996-03-05 | Valleylab Inc. | Impedance and temperature generator control |
US6514246B1 (en) * | 1993-10-14 | 2003-02-04 | Ep Technologies, Inc. | Systems and methods for forming large lesions in body tissue using curvilinear electrode elements |
US5599345A (en) * | 1993-11-08 | 1997-02-04 | Zomed International, Inc. | RF treatment apparatus |
US6216043B1 (en) * | 1994-03-04 | 2001-04-10 | Ep Technologies, Inc. | Asymmetric multiple electrode support structures |
US5505730A (en) * | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
US5735846A (en) * | 1994-06-27 | 1998-04-07 | Ep Technologies, Inc. | Systems and methods for ablating body tissue using predicted maximum tissue temperature |
US5623940A (en) * | 1994-08-02 | 1997-04-29 | S.L.T. Japan Co., Ltd. | Catheter apparatus with a sensor |
US6214002B1 (en) * | 1994-10-07 | 2001-04-10 | Ep Technologies, Inc. | Structures and methods for deploying electrode elements |
US6544262B2 (en) * | 1994-10-07 | 2003-04-08 | Ep Technologies, Inc. | Structures and methods for deploying electrode elements |
US5707336A (en) * | 1995-01-09 | 1998-01-13 | Cardassist Incorporated | Ventricular assist device |
US5707218A (en) * | 1995-04-19 | 1998-01-13 | Nimbus, Inc. | Implantable electric axial-flow blood pump with blood cooled bearing |
US5741248A (en) * | 1995-06-07 | 1998-04-21 | Temple University-Of The Commonwealth System Of Higher Education | Fluorochemical liquid augmented cryosurgery |
US6837888B2 (en) * | 1995-06-07 | 2005-01-04 | Arthrocare Corporation | Electrosurgical probe with movable return electrode and methods related thereto |
US6179833B1 (en) * | 1995-06-09 | 2001-01-30 | Engineering & Research Associates, Inc. | Apparatus for thermal ablation |
US6039731A (en) * | 1995-06-09 | 2000-03-21 | Engineering & Research Associates, Inc. | Apparatus and method for determining the extent of ablation |
US5873852A (en) * | 1995-07-10 | 1999-02-23 | Interventional Technologies | Device for injecting fluid into a wall of a blood vessel |
US6023638A (en) * | 1995-07-28 | 2000-02-08 | Scimed Life Systems, Inc. | System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue |
US6210367B1 (en) * | 1995-09-06 | 2001-04-03 | Microwave Medical Systems, Inc. | Intracorporeal microwave warming method and apparatus |
US5891136A (en) * | 1996-01-19 | 1999-04-06 | Ep Technologies, Inc. | Expandable-collapsible mesh electrode structures |
US5891135A (en) * | 1996-01-19 | 1999-04-06 | Ep Technologies, Inc. | Stem elements for securing tubing and electrical wires to expandable-collapsible electrode structures |
US5727569A (en) * | 1996-02-20 | 1998-03-17 | Cardiothoracic Systems, Inc. | Surgical devices for imposing a negative pressure to fix the position of cardiac tissue during surgery |
US5728094A (en) * | 1996-02-23 | 1998-03-17 | Somnus Medical Technologies, Inc. | Method and apparatus for treatment of air way obstructions |
WO1997032532A1 (en) * | 1996-03-05 | 1997-09-12 | Vnus Medical Technologies, Inc. | Vascular catheter-based system for heating tissue |
US6033397A (en) * | 1996-03-05 | 2000-03-07 | Vnus Medical Technologies, Inc. | Method and apparatus for treating esophageal varices |
US6346104B2 (en) * | 1996-04-30 | 2002-02-12 | Western Sydney Area Health Service | System for simultaneous unipolar multi-electrode ablation |
US5876340A (en) * | 1997-04-17 | 1999-03-02 | Irvine Biomedical, Inc. | Ablation apparatus with ultrasonic imaging capabilities |
US6050992A (en) * | 1997-05-19 | 2000-04-18 | Radiotherapeutics Corporation | Apparatus and method for treating tissue with multiple electrodes |
US6217576B1 (en) * | 1997-05-19 | 2001-04-17 | Irvine Biomedical Inc. | Catheter probe for treating focal atrial fibrillation in pulmonary veins |
US5876399A (en) * | 1997-05-28 | 1999-03-02 | Irvine Biomedical, Inc. | Catheter system and methods thereof |
US6547788B1 (en) * | 1997-07-08 | 2003-04-15 | Atrionx, Inc. | Medical device with sensor cooperating with expandable member |
WO1999003413A1 (en) * | 1997-07-17 | 1999-01-28 | Vnus Medical Technologies, Inc. | Expandable catheter having improved electrode design, and method for applying energy |
US6014579A (en) * | 1997-07-21 | 2000-01-11 | Cardiac Pathways Corp. | Endocardial mapping catheter with movable electrode |
US5891138A (en) * | 1997-08-11 | 1999-04-06 | Irvine Biomedical, Inc. | Catheter system having parallel electrodes |
US6045549A (en) * | 1997-09-30 | 2000-04-04 | Somnus Medical Technologies, Inc. | Tissue ablation apparatus and device for use therein and method |
US6200311B1 (en) * | 1998-01-20 | 2001-03-13 | Eclipse Surgical Technologies, Inc. | Minimally invasive TMR device |
US6355031B1 (en) * | 1998-02-19 | 2002-03-12 | Curon Medical, Inc. | Control systems for multiple electrode arrays to create lesions in tissue regions at or near a sphincter |
US6053909A (en) * | 1998-03-27 | 2000-04-25 | Shadduck; John H. | Ionothermal delivery system and technique for medical procedures |
US6370644B1 (en) * | 1998-04-07 | 2002-04-09 | Micron Technology, Inc. | Device for blocking bus transactions during reset |
US6714822B2 (en) * | 1998-04-30 | 2004-03-30 | Medtronic, Inc. | Apparatus and method for expanding a stimulation lead body in situ |
US7425212B1 (en) * | 1998-06-10 | 2008-09-16 | Asthmatx, Inc. | Devices for modification of airways by transfer of energy |
US20040031494A1 (en) * | 1998-06-10 | 2004-02-19 | Broncus Technologies, Inc. | Methods of treating asthma |
US6849073B2 (en) * | 1998-07-07 | 2005-02-01 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US6029091A (en) * | 1998-07-09 | 2000-02-22 | Irvine Biomedical, Inc. | Catheter system having lattice electrodes |
US6212433B1 (en) * | 1998-07-28 | 2001-04-03 | Radiotherapeutics Corporation | Method for treating tumors near the surface of an organ |
US6338727B1 (en) * | 1998-08-13 | 2002-01-15 | Alsius Corporation | Indwelling heat exchange catheter and method of using same |
US6183468B1 (en) * | 1998-09-10 | 2001-02-06 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6036689A (en) * | 1998-09-24 | 2000-03-14 | Tu; Lily Chen | Ablation device for treating atherosclerotic tissues |
US6526320B2 (en) * | 1998-11-16 | 2003-02-25 | United States Surgical Corporation | Apparatus for thermal treatment of tissue |
US6200332B1 (en) * | 1999-07-09 | 2001-03-13 | Ceramoptec Industries, Inc. | Device and method for underskin laser treatments |
US20030069570A1 (en) * | 1999-10-02 | 2003-04-10 | Witzel Thomas H. | Methods for repairing mitral valve annulus percutaneously |
US6529756B1 (en) * | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
US6723091B2 (en) * | 2000-02-22 | 2004-04-20 | Gyrus Medical Limited | Tissue resurfacing |
US6840243B2 (en) * | 2000-03-04 | 2005-01-11 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
US6544226B1 (en) * | 2000-03-13 | 2003-04-08 | Curon Medical, Inc. | Operative devices that can be removably fitted on catheter bodies to treat tissue regions in the body |
US6673068B1 (en) * | 2000-04-12 | 2004-01-06 | Afx, Inc. | Electrode arrangement for use in a medical instrument |
US6689693B2 (en) * | 2000-08-30 | 2004-02-10 | Micron Technology, Inc. | Methods for utilization of disappearing silicon hard mask for fabrication of semiconductor structures |
US20030050631A1 (en) * | 2000-12-29 | 2003-03-13 | Afx, Inc. | Tissue ablation apparatus with a sliding ablation instrument and method |
US6699243B2 (en) * | 2001-09-19 | 2004-03-02 | Curon Medical, Inc. | Devices, systems and methods for treating tissue regions of the body |
US20030065371A1 (en) * | 2001-09-28 | 2003-04-03 | Shutaro Satake | Radiofrequency thermal balloon catheter |
US6692492B2 (en) * | 2001-11-28 | 2004-02-17 | Cardiac Pacemaker, Inc. | Dielectric-coated ablation electrode having a non-coated window with thermal sensors |
US6881213B2 (en) * | 2002-06-28 | 2005-04-19 | Ethicon, Inc. | Device and method to expand treatment array |
US6866662B2 (en) * | 2002-07-23 | 2005-03-15 | Biosense Webster, Inc. | Ablation catheter having stabilizing array |
US6852110B2 (en) * | 2002-08-01 | 2005-02-08 | Solarant Medical, Inc. | Needle deployment for temperature sensing from an electrode |
US7186251B2 (en) * | 2003-03-27 | 2007-03-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
US20060062808A1 (en) * | 2004-09-18 | 2006-03-23 | Asthmatx, Inc. | Inactivation of smooth muscle tissue |
US20080004596A1 (en) * | 2006-05-25 | 2008-01-03 | Palo Alto Institute | Delivery of agents by microneedle catheter |
US20090018538A1 (en) * | 2007-07-12 | 2009-01-15 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
US20090030477A1 (en) * | 2007-07-24 | 2009-01-29 | Asthmatx, Inc. | System and method for controlling power based on impedance detection, such as controlling power to tissue treatment devices |
US20090043301A1 (en) * | 2007-08-09 | 2009-02-12 | Asthmatx, Inc. | Monopolar energy delivery devices and methods for controlling current density in tissue |
Cited By (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10058370B2 (en) | 1997-04-07 | 2018-08-28 | Boston Scientific Scimed, Inc. | Method for treating a lung |
US20090192508A1 (en) * | 1997-04-07 | 2009-07-30 | Asthmatx, Inc. | Modification of airways by application of mechanical energy |
US9027564B2 (en) | 1997-04-07 | 2015-05-12 | Asthmatx, Inc. | Method for treating a lung |
US20070106296A1 (en) * | 1997-04-07 | 2007-05-10 | Asthmatx, Inc. | Expandable electode devices and methods of treating bronchial tubes |
US9956023B2 (en) | 1997-04-07 | 2018-05-01 | Boston Scientific Scimed, Inc. | System for treating a lung |
US8944071B2 (en) | 1997-04-07 | 2015-02-03 | Asthmatx, Inc. | Method for treating an asthma attack |
US8161978B2 (en) | 1997-04-07 | 2012-04-24 | Asthmatx, Inc. | Methods for treating asthma by damaging nerve tissue |
US20090143705A1 (en) * | 1997-04-07 | 2009-06-04 | Asthmatx, Inc. | Modification of airways by application of ultrasound energy |
US7938123B2 (en) | 1997-04-07 | 2011-05-10 | Asthmatx, Inc. | Modification of airways by application of cryo energy |
US8640711B2 (en) | 1997-04-07 | 2014-02-04 | Asthmatx, Inc. | Method for treating an asthma attack |
US11033317B2 (en) | 1997-04-07 | 2021-06-15 | Boston Scientific Scimed, Inc. | Methods for treating a lung |
US8267094B2 (en) | 1997-04-07 | 2012-09-18 | Asthmatx, Inc. | Modification of airways by application of ultrasound energy |
US8584681B2 (en) | 1998-01-07 | 2013-11-19 | Asthmatx, Inc. | Method for treating an asthma attack |
US7921855B2 (en) | 1998-01-07 | 2011-04-12 | Asthmatx, Inc. | Method for treating an asthma attack |
US9789331B2 (en) | 1998-01-07 | 2017-10-17 | Boston Scientific Scimed, Inc. | Methods of treating a lung |
US8443810B2 (en) | 1998-06-10 | 2013-05-21 | Asthmatx, Inc. | Methods of reducing mucus in airways |
US7992572B2 (en) | 1998-06-10 | 2011-08-09 | Asthmatx, Inc. | Methods of evaluating individuals having reversible obstructive pulmonary disease |
US20060137698A1 (en) * | 1998-06-10 | 2006-06-29 | Asthmatx, Inc. | Methods for treating airways |
US20070123958A1 (en) * | 1998-06-10 | 2007-05-31 | Asthmatx, Inc. | Apparatus for treating airways in the lung |
US8181656B2 (en) | 1998-06-10 | 2012-05-22 | Asthmatx, Inc. | Methods for treating airways |
US8733367B2 (en) | 1998-06-10 | 2014-05-27 | Asthmatx, Inc. | Methods of treating inflammation in airways |
US8534291B2 (en) | 1998-06-10 | 2013-09-17 | Asthmatx, Inc. | Methods of treating inflammation in airways |
US8464723B2 (en) | 1998-06-10 | 2013-06-18 | Asthmatx, Inc. | Methods of evaluating individuals having reversible obstructive pulmonary disease |
US8459268B2 (en) | 2000-03-27 | 2013-06-11 | Asthmatx, Inc. | Methods for treating airways |
US9358024B2 (en) | 2000-03-27 | 2016-06-07 | Asthmatx, Inc. | Methods for treating airways |
US10278766B2 (en) | 2000-03-27 | 2019-05-07 | Boston Scientific Scimed, Inc. | Methods for treating airways |
US10561458B2 (en) | 2000-03-27 | 2020-02-18 | Boston Scientific Scimed, Inc. | Methods for treating airways |
US8251070B2 (en) | 2000-03-27 | 2012-08-28 | Asthmatx, Inc. | Methods for treating airways |
US7837679B2 (en) | 2000-10-17 | 2010-11-23 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
US8465486B2 (en) | 2000-10-17 | 2013-06-18 | Asthmatx, Inc. | Modification of airways by application of energy |
US9033976B2 (en) | 2000-10-17 | 2015-05-19 | Asthmatx, Inc. | Modification of airways by application of energy |
US20070100390A1 (en) * | 2000-10-17 | 2007-05-03 | Asthmatx, Inc. | Modification of airways by application of energy |
US9931163B2 (en) | 2000-10-17 | 2018-04-03 | Boston Scientific Scimed, Inc. | Energy delivery devices |
US8257413B2 (en) | 2000-10-17 | 2012-09-04 | Asthmatx, Inc. | Modification of airways by application of energy |
US8888769B2 (en) | 2000-10-17 | 2014-11-18 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
US7854734B2 (en) | 2000-10-17 | 2010-12-21 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
US10016592B2 (en) | 2001-10-17 | 2018-07-10 | Boston Scientific Scimed, Inc. | Control system and process for application of energy to airway walls and other mediums |
US10953170B2 (en) | 2003-05-13 | 2021-03-23 | Nuvaira, Inc. | Apparatus for treating asthma using neurotoxin |
US9339618B2 (en) | 2003-05-13 | 2016-05-17 | Holaira, Inc. | Method and apparatus for controlling narrowing of at least one airway |
US8172827B2 (en) | 2003-05-13 | 2012-05-08 | Innovative Pulmonary Solutions, Inc. | Apparatus for treating asthma using neurotoxin |
US7949407B2 (en) | 2004-11-05 | 2011-05-24 | Asthmatx, Inc. | Energy delivery devices and methods |
US7853331B2 (en) | 2004-11-05 | 2010-12-14 | Asthmatx, Inc. | Medical device with procedure improvement features |
US20060247619A1 (en) * | 2004-11-05 | 2006-11-02 | Asthmatx, Inc. | Medical device with procedure improvement features |
US10076380B2 (en) | 2004-11-05 | 2018-09-18 | Boston Scientific Scimed, Inc. | Energy delivery devices and methods |
US10398502B2 (en) | 2004-11-05 | 2019-09-03 | Boston Scientific Scimed, Inc. | Energy delivery devices and methods |
US20070106292A1 (en) * | 2004-11-05 | 2007-05-10 | Asthmatx, Inc. | Energy delivery devices and methods |
US8480667B2 (en) | 2004-11-05 | 2013-07-09 | Asthmatx, Inc. | Medical device with procedure improvement features |
US8920413B2 (en) | 2004-11-12 | 2014-12-30 | Asthmatx, Inc. | Energy delivery devices and methods |
US20070123961A1 (en) * | 2004-11-12 | 2007-05-31 | Asthmax, Inc. | Energy delivery and illumination devices and methods |
US7931647B2 (en) | 2006-10-20 | 2011-04-26 | Asthmatx, Inc. | Method of delivering energy to a lung airway using markers |
US10368941B2 (en) | 2007-07-12 | 2019-08-06 | Boston Scientific Scimed, Inc. | Systems and methods for delivering energy to passageways in a patient |
US8235983B2 (en) * | 2007-07-12 | 2012-08-07 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
US11478299B2 (en) | 2007-07-12 | 2022-10-25 | Boston Scientific Scimed, Inc. | Systems and methods for delivering energy to passageways in a patient |
US8489192B1 (en) | 2008-02-15 | 2013-07-16 | Holaira, Inc. | System and method for bronchial dilation |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
US9125643B2 (en) | 2008-02-15 | 2015-09-08 | Holaira, Inc. | System and method for bronchial dilation |
US8731672B2 (en) | 2008-02-15 | 2014-05-20 | Holaira, Inc. | System and method for bronchial dilation |
US11058879B2 (en) | 2008-02-15 | 2021-07-13 | Nuvaira, Inc. | System and method for bronchial dilation |
US8961508B2 (en) | 2008-05-09 | 2015-02-24 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US11937868B2 (en) | 2008-05-09 | 2024-03-26 | Nuvaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8088127B2 (en) | 2008-05-09 | 2012-01-03 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8808280B2 (en) | 2008-05-09 | 2014-08-19 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8821489B2 (en) | 2008-05-09 | 2014-09-02 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US10149714B2 (en) | 2008-05-09 | 2018-12-11 | Nuvaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8961507B2 (en) | 2008-05-09 | 2015-02-24 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8226638B2 (en) | 2008-05-09 | 2012-07-24 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US9668809B2 (en) | 2008-05-09 | 2017-06-06 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US20100160906A1 (en) * | 2008-12-23 | 2010-06-24 | Asthmatx, Inc. | Expandable energy delivery devices having flexible conductive elements and associated systems and methods |
US9005195B2 (en) | 2009-10-27 | 2015-04-14 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9649153B2 (en) | 2009-10-27 | 2017-05-16 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8740895B2 (en) | 2009-10-27 | 2014-06-03 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8777943B2 (en) | 2009-10-27 | 2014-07-15 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9675412B2 (en) | 2009-10-27 | 2017-06-13 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9017324B2 (en) | 2009-10-27 | 2015-04-28 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9931162B2 (en) | 2009-10-27 | 2018-04-03 | Nuvaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8932289B2 (en) | 2009-10-27 | 2015-01-13 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US10610283B2 (en) | 2009-11-11 | 2020-04-07 | Nuvaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US9649154B2 (en) | 2009-11-11 | 2017-05-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US11389233B2 (en) | 2009-11-11 | 2022-07-19 | Nuvaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US9149328B2 (en) | 2009-11-11 | 2015-10-06 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US11712283B2 (en) | 2009-11-11 | 2023-08-01 | Nuvaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US20120116378A1 (en) * | 2010-04-26 | 2012-05-10 | Minerva Surgical, Inc. | Endometrial ablation with a device that conforms to symmetric or asymmetric uterine cavities |
US9770293B2 (en) | 2012-06-04 | 2017-09-26 | Boston Scientific Scimed, Inc. | Systems and methods for treating tissue of a passageway within a body |
US9592086B2 (en) | 2012-07-24 | 2017-03-14 | Boston Scientific Scimed, Inc. | Electrodes for tissue treatment |
US9572619B2 (en) | 2012-11-02 | 2017-02-21 | Boston Scientific Scimed, Inc. | Medical device for treating airways and related methods of use |
US9272132B2 (en) | 2012-11-02 | 2016-03-01 | Boston Scientific Scimed, Inc. | Medical device for treating airways and related methods of use |
US9283374B2 (en) | 2012-11-05 | 2016-03-15 | Boston Scientific Scimed, Inc. | Devices and methods for delivering energy to body lumens |
US10492859B2 (en) | 2012-11-05 | 2019-12-03 | Boston Scientific Scimed, Inc. | Devices and methods for delivering energy to body lumens |
US9974609B2 (en) | 2012-11-05 | 2018-05-22 | Boston Scientific Scimed, Inc. | Devices and methods for delivering energy to body lumens |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
US9814618B2 (en) | 2013-06-06 | 2017-11-14 | Boston Scientific Scimed, Inc. | Devices for delivering energy and related methods of use |
US11801090B2 (en) | 2013-08-09 | 2023-10-31 | Boston Scientific Scimed, Inc. | Expandable catheter and related methods of manufacture and use |
US10478247B2 (en) | 2013-08-09 | 2019-11-19 | Boston Scientific Scimed, Inc. | Expandable catheter and related methods of manufacture and use |
US20150265458A1 (en) * | 2014-02-21 | 2015-09-24 | Circuit Therapeutics, Inc. | System and method for therapeutic management of unproductive cough |
US10858735B2 (en) | 2014-09-10 | 2020-12-08 | Applied Materials, Inc. | Alignment systems employing actuators providing relative displacement between lid assemblies of process chambers and substrates, and related methods |
US10939958B2 (en) | 2016-06-27 | 2021-03-09 | Galary, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
US11369433B2 (en) | 2016-06-27 | 2022-06-28 | Galvanize Therapeutics, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
US10702337B2 (en) | 2016-06-27 | 2020-07-07 | Galary, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
CN107374725A (en) * | 2017-08-31 | 2017-11-24 | 苏州信迈医疗器械有限公司 | A kind of multipole ablating device |
CN111227929A (en) * | 2018-11-29 | 2020-06-05 | 上海安臻医疗科技有限公司 | Adjustable bronchus thermoforming pipe |
US20210038289A1 (en) * | 2019-08-05 | 2021-02-11 | Karl Storz Se & Co. Kg | Endoscopic device |
CN112315410A (en) * | 2019-08-05 | 2021-02-05 | 卡尔史托斯股份有限公司 | Endoscope device |
Also Published As
Publication number | Publication date |
---|---|
US7425212B1 (en) | 2008-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7425212B1 (en) | Devices for modification of airways by transfer of energy | |
CA2370223C (en) | Modification of airways by application of energy | |
US9931163B2 (en) | Energy delivery devices | |
CA2426144C (en) | Modification of airways by application of energy | |
US10058370B2 (en) | Method for treating a lung | |
AU2001212109A1 (en) | Modification of airways by application of energy | |
US20180360537A1 (en) | Energy delivery devices and methods | |
US10016592B2 (en) | Control system and process for application of energy to airway walls and other mediums | |
US9789331B2 (en) | Methods of treating a lung | |
US6411852B1 (en) | Modification of airways by application of energy | |
US20020004644A1 (en) | Methods of deploying helical diagnostic and therapeutic element supporting structures within the body |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ASTHMATX, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRONCUS TECHNOLOGIES, INC.;REEL/FRAME:022886/0969 Effective date: 20031226 Owner name: BRONCUS TECHNOLOGIES, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DANEK, CHRISTOPHER JAMES;LOOMAS, BRYAN;BIGGS, MICHAEL;AND OTHERS;REEL/FRAME:022886/0942;SIGNING DATES FROM 20000211 TO 20000314 |
|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ASTHMATX, INC.;REEL/FRAME:040510/0149 Effective date: 20101026 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |